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ABSTRACT 
Operation Iraqi Freedom and Operation Enduring Freedom have affected the mental 
health of the U.S. military, as evidenced by an increasing trend in mental health illness. 
This thesis evaluates the effects of deployment history on major depression and substance 
abuse in the active duty population from 2001 to 2006. The research specifically 
evaluates cumulative effects of deployment (location, total days, frequency of separate 
tours) on major depression and substance abuse across the different branches of the 
military.  
Probit regressions were used to estimate the effects of deployment characteristics 
on the rate of major depression and substance abuse using 2001–2006 data from 
TRICARE and DMDC, and all models control for service members' demographic and 
service characteristics, as well as time trend. 
In general, the results support that deployments, especially to Iraq and 
Afghanistan, significantly affect the probability of active duty personnel across all 
services being diagnosed with major depression or substance abuse. Furthermore, 
personnel deployed only once under OEF/OIF have the highest probability of both 
conditions compared to those with multiple deployments, indicating a selection bias: 
those diagnosed were excluded from future deployments. Lastly, the risk of both 
conditions, in particular substance abuse, increases as cumulative days of deployment 
increases.  
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In response to the attacks of September 11, 2001, the United States entered 
combat operations in Afghanistan and Iraq in 2003. The all-volunteer force entered into 
its first major post-cold war conflict and one of the largest combat operations since the 
Vietnam Conflict. Nearly nine years have passed since the United States started combat 
operations in Afghanistan and Iraq, with an estimated 1.6 million wartime veterans (Seal, 
2010) deployed to two theaters.  
Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) have 
affected the mental health of the entire military, as evidenced by an increasing trend in 
mental health illness, depression, and substance abuse being the top two diagnoses. 
Mental health illness affects readiness, and the cost of care to military and society. 
Mental health illness is not isolated to military communities; it affects all of society. The 
increasing trend in mental health illness, particularly depression and substance abuse pose 
important issues that need to be addressed by military planners. Planners and leadership 
need to be able to respond to demands of increased care related to mental health illness, 
as well as better manage the incidence and prevalence of mental health illness. 
Understanding the risk factors associated with mental health illness and targeting 
preventative treatment by optimizing tour length, location, and rotation should alleviate 
some of the concerns surrounding mental health illness in the military. Understanding 
and concentrating on preventative measures for those at risk will improve readiness. 
Knowing how deployment length and frequency affects military members, leadership and 
policy makers will help improve decisions regarding deployments to minimize the risk of 
mental health illness.  
B. RESEARCH QUESTIONS 
Existing studies provide important information on major depression and substance 
abuse in OEF and OIF environments, but they do have some limitations. The objective of 
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this thesis is to provide military planners, leadership and policy makers with expanded 
and more comprehensive information to aid in the rising concerns of substance abuse and 
major depression effects across the branches of service by analyzing the following 
research questions. 
• What are the rates of major depression and substance abuse among all 
active duty enlisted personnel and how do the rates differ by service and 
deployment?  
• How do deployment location (specifically, Iraq and Afghanistan) affect 
the probability of being diagnosed with major depression and substance 
abuse? 
• Is there a cumulative effect of deployments (i.e., frequency of separate 
tours and total days in theater) on major depression and substance abuse? 
To examine the research questions, multivariate analysis is used for active duty 
enlisted personnel from 2001 to 2006 for the Army, Marine Corps, Air Force, and Navy. 
A separate analysis is performed for each branch of service and the results compared.  
C. STUDY OVERVIEW AND SIGNIFICANCE 
The empirical approach for this thesis is a combination of descriptive statistics 
and multivariate analytical methods to examine the rate of major depression and 
substance abuse, the probability of being diagnosed with either in the face of deployment, 
and the cumulative effects deployments have on major depression and substance abuse. 
This thesis embodies four main sections to address the importance of this subject. The 
first section focuses on an overview of major depression and substance abuse and a 
review of existing relevant literature on the effects of these two mental health conditions 
on military members. The focus is centered on the impact of deployments to OEF and 
OIF have on U.S. fighting forces; thus, providing a framework to understand the risks 
faced by military members and the significance of identifying, treating, and tackling the 
issues of the two mental health conditions, major depression and substance abuse.  
The second and third section of this thesis concentrates on the data and 
methodology used for analysis. TRICARE, Defense Enrollment Eligibility Reporting 
System (DEERS) and Defense Manpower Data Center’s (DMDC) Contingency Tracking 
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System (CTS) data are formulated into analytical working files allowing the analysis of 
major depression and substance abuse from 2001 to 2006 across the four branches of 
service. To perform the analysis, the preferred methodology and multivariate models 
describing key variables of interest is described. The methodology and multivariate 
analysis is vital to analyze the effects deployments have on enlisted active duty military 
members’ risks of diagnosis with major depression or substance abuse.  
The final sections of this thesis address the results and discuss the findings 
compared across the branches of service. The inherent dangerous nature of deployments 
under OEF and OIF and the effect on active duty military members places them at risk of 
being diagnosed with either of the two mental health illness. The final sections provide 
military planners invaluable data and information to arm them with the knowledge to 
address concerns of mental health amongst deployed military members. The hope is that 
military planners will use the information provided in this thesis to evaluate deployment 
structures to minimize the risks to active duty enlisted personnel in the Army, Marine 
Corps, Air Force, and Navy of being diagnosed with either or both of the mental health 
illnesses, major depression or substance abuse. 
 4
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II. LITERATURE REVIEW 
A. INTRODUCTION 
This chapter presents an overview of current literature on the mental health 
disorders depression and substance abuse in the military population that has deployed to 
Afghanistan and Iraq. Section B addresses the definitions of depression and its symptoms 
and treatment, and section C addresses the definitions of substance abuse symptoms and 
treatments. In Section D, past studies on depression and substance abuse are reviewed. 
Section E evaluates shortcomings in the current literature in depression and substance 
abuse. Finally, Section F summarizes this chapter and key points, as well as address how 
this thesis helps the current literature in depression and substance abuse in the deployed 
military population.  
In 2001, in response to the attacks on September 11, the United States entered 
combat operations in Afghanistan and in 2003 Iraq. The all-volunteer force entered into 
its first post-cold war conflict and one of the largest combat operations since the Vietnam 
Conflict. Nearly nine years have passed since the Untied States started combat operations 
in Afghanistan and Iraq, with an estimated 1.6 million wartime veterans (Seal, 2010) 
deployed to two theaters.  
Given the sustained operations and nature of combat, there are mounting concerns 
and growing evidence that combat operations impact the mental health of troops, 
affecting readiness and productivity, and increasing costs to the military and society as a 
whole. Recent studies support the theory that deployment to Afghanistan—Operation 
Enduring Freedom (OEF)—and Iraq—Operation Iraqi Freedom (OIF)—may place troops 
at increased risk for mental health illnesses, such as Post Traumatic Stress Disorder 
(PTSD), depression and substance abuse. The effect of mental health issues on troops is 
not as clearly identifiable as physical wounds, thus complicating the overall impact. 
Military leadership and policy makers are exceedingly concerned with the escalating 
rates of mental health issues arising from sustained military operations. In response to 
concerns about the mental health of military personnel, multiple studies have been 
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conducted. A major report conducted by the RAND Corporation focused on some of 
these “invisible” wounds, and their impacts on deploying troops. The RAND report 
focused on PTSD, major depression and traumatic brain injury diagnosed in OEF and 
OIF veterans and intended to help shape the decisions of mental health treatment 
providers, health policymakers, particularly those charged with caring for veterans, active 
service personnel, their families and the concerned public (Tanielian, 2008). Of course, 
the concerns of mental health impacts on troops are not limited to only the United States, 
but also of U.S. allies.  
The increased operational tempos seen with OIF and OEF have resulted in 
variable deployment lengths, multiple deployments and unpredictable time at home. 
“Dwell time” (Harben, 2009) between deployments impacts the readiness and mental 
health of our troops (Harben; Hoge et al., 2004; Kline et al., 2010). Several things are 
suspected in contributing to depression and substance abuse in military personnel who 
have been deployed. A possible contributing factor may be the nature in which the 
current conflicts are fought. Past conflicts relied on draftees to augment the force; 
however, today’s military structure is an all-voluntary force. Gaps in the “need and use of 
care” impact mental health outcomes of military personnel. For example, as pointed out 
in the RAND report, “there is a large gap between the need for mental health services and 
the use of such services—a pattern that appears to stem from structural aspects of 
services (wait times, availability of providers), as well as from personal and cultural 
factors” (Tanielian, 2008). The stigma of mental health illness is a challenge faced by all 
branches of the military and extensively addressed in the Rand report. Length of tours is 
also suspected to increase the risk for developing a mental health illness, such as PTSD, 
depression and substance abuse (Tanielian, 2008). Deployment duration greater than 13 
months was found to increase the use of alcohol in UK Armed Forces personnel, 
supporting that length of tours increases risk of mental health illness (Rona et al., 2008). 
The number of deployments and the location of deployment appear to have an impact on 
the risk of developing a mental health illness. Tanielian (2008), remarks, “troops are 
seeing more-frequent deployments, of greater lengths…factors thought to create a more 
stressful environment for servicemembers.” Interestingly, Rona et al. found that the 
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number of deployments was less consistent than the duration of deployments for UK 
Armed Forces personnel and may actually decrease the likelihood of mental health 
symptoms in future deployments. The branch of service, preparation for deployment, 
leadership environment, age of personnel and marital status are also factors that appear to 
contribute to the possible risk for mental health issues in troops. Additionally, full time 
active duty status versus reserve component status seems to have an impact on the 
prevalence of mental health illness, such as depression and substance abuse.  
The objective of this chapter is to examine literature that addresses the effects of 
depression and substance abuse amongst military personnel. Of particular interest are the 
effects of depression and substance abuse related to deployment length, and location 
affecting the four branches, Navy, Marine Corps, Army and Air Force, as well as the 
impact on reserve and National Guard.  
B. DEFINITIONS OF DEPRESSION, SYMPTOMS AND TREATMENT 
Depression is a common psychological disorder that affects about 121 million 
people worldwide and is among the leading causes of disability (World Health 
Organization, 2010b). Depression can occur in people of all ages, gender, socio-
economic backgrounds and lifestyles. A number of factors may contribute to depression, 
such as the death of loved ones, history of violent crime or physical/mental abuse, 
medications, genetics, change in job or income, and natural disasters. In addition, 
witnessing or experiencing traumatic events, such as war or divorce, could lead to 
depression. Depression may lead to substantial long-term effects on individuals and 
society, manifested by recurrent problems adapting to the demands of normal life and 
increased costs of health care to the individuals and society. Typically, depression is not a 
life threatening disease; however, in severe cases, it may lead to suicide. Diagnosis of 
depression is characterized by an episode of depression lasting more than two weeks 
while meeting at least five of the Diagnostic and Statistical Manual of Mental Disorders 




feelings of sadness or emptiness, reduced interest in activities that used to be enjoyed, 
loss of energy, difficulty concentrating, difficulty holding conversations or paying 
attention and suicidal thoughts or intentions.  
Depression is often diagnosed in primary care settings with treatment consisting 
of a combination of pharmacotherapy and psychotherapy. Tables 1 and 2 represent the 
diagnostic criteria from the DSM-IV that health care providers must use to assign a 
diagnosis of depression. The specificity of the diagnostic criteria is precise and illustrates 
the differences between types of depression diagnoses. Pharmacotherapy treatment 
consists of anti-depression medications, such as Prozac, Paxil, Welbutrin and Zoloft. 
Symptomotology is a vital aspect of the treatment and medication prescription selection.  
Table 1.   Criteria for Major Depressive Episode (From: American Psychiatric 
Association, 1994)  
Five (or more) of the following symptoms have been present during the same 2-week 
period and represent a change from previous functioning; at least one of the symptoms is 
either (1) dressed mood or (2) loss of interest or pleasure.  
• Depressed mood most of the day, nearly every day, as indicated by either 
subjective report (e.g., feels sad or empty) or observation made by others (e.g., 
appears tearful). 
• Markedly diminished interest or pleasure in all, or almost all, activities most of 
the day, nearly every day (as indicated by either subjective account or observation 
made by others. 
• Significant weight loss when not dieting or weight gain (e.g., a change of more 
than 5 percent of body weight in a month), or decrease or increase in appetite 
nearly every day.  
• Insomnia or hypersomnia nearly every day.  
• Psychomotor agitation or retardation nearly every day (observable by others, not 
merely subjective feelings of restlessness or being slowed down).  
• Fatigue or loss of energy nearly every day.  
• Feelings of worthlessness or excessive or inappropriate guilt (which may be 
delusional) nearly every day (not merely self-reproach or guilt about being sick).  
• Diminished ability to think or concentrate, or indecisiveness, nearly every day 
(either by subjective account or as observed by others).  
• Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation 
without a specific plan 
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Table 2.   Diagnostic criteria for 296.2x major Depressive Disorder, Single Episode 
(From: American Psychiatric Association, 1994) 
• Presence of criteria for Major Depressive Episode 
• The Major Depressive Episode is not better accounted for by Schizoaffective 
Disorder and is not superimposed on Schizophrenia, Schizophreniform Disorder, 
Delusional Disorder, or Psychotic Disorder Not Otherwise Specified.  
• There has never been a Manic Episode, a Mixed Episode, or a Hypomanic 
Episode. This exclusion does not apply if all the manic-like, mixed-like, or 
hypomanic-like episodes are substance or treatment induced or are due to the 
direct physiological effects of a general medical condition.  
Diagnostic criteria for 296.3x Major Depressive Disorder, Recurrent 
• Presence of two or more Major Depressive Episodes (see Table 1.1). Note: 
To be considered separate episodes, there must be an interval of at least 
two consecutive months in which criteria are not met for a Major 
Depressive Episode. 
• The Major Depressive Episodes are not better accounted for by 
Schizoaffective Disorder and are not superimposed on Schizophrenia, 
Schizphreniform Disorder, Delusional Disorder, or Psychotic Disorder 
Not Otherwise Specified.  
• There has never been a Manic Episode, a Mixed Episode, or a Hypomanic 
Episode. This exclusion does not apply if all the manic-like, mixed-like, or 
hypomanic-like episodes are substance or treatment induced or are due to 
the direct physiological effects of a general medical condition 
 
An important component of the epidemiology of depression is the pattern of 
comorbidities. People diagnosed with depression may be at risk for other disorders; 
current literature identifies common comorbidities, such as Post-Traumatic Stress 
Disorder (PTSD), adjustment disorders with mixed emotional features, anxiety disorders 
and substance abuse (Riddle, 2008). In a study by Riddle et al. that evaluated self-
reported combat stress indicators, findings showed that, during a six-month period, in 
addition to depression there were (25 percent) adjustment disorders with mixed emotional 
features, (10 percent) anxiety disorders, (20 percent) occupational problems, (5 percent) 
combat stress, (5 percent) bereavement and (10 percent) other diagnoses. In a recent 
study, the rates of comorbidity with veterans diagnosed with clinical depression found the 
rate of PTSD was 36 percent–51 percent (Chan, 2009). 
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C. DEFINITIONS OF SUBSTANCE ABUSE, SYMPTOMS AND 
TREATMENT 
Substance abuse, the harmful or hazardous use of psychoactive substances, is a 
psychological disorder that clusters around behavioral, cognitive and physiological 
phenomena where a desire to continue taking a particular substance persists despite 
potential harmful consequences. Substances range from prescription drugs to legal 
substances, such as cigarettes and alcohol to illegal drugs; however, the most common 
substance abused in the military is alcohol. An estimated 78.3 million people worldwide 
have an alcohol disorder and 15.3 million people worldwide have a drug disorder (World 
Health Organization, 2010a). While genetic predisposition is a primary factor in 
substance abuse, other contributing factors can play a role in development (World Health 
Organization, 2010a). Some additional contributing factors often confused as symptoms, 
are exposure to a trauma, relationship issues, stress, witnessing a violent crime, military 
combat and peer pressure. To effectively treat and identify those at risk, it is crucial to 
distinguish between indicators as symptoms of substance abuse and indicators as 
determining risk factors. Table 3 contains the DSM-IV diagnostic criteria of substance 
abuse and demonstrates the difference between what is a symptom and what is a factor. 
The characteristic features of substance abuse are a pattern of use leading to significant 
impairment in functioning including recurrent failure to meet work obligations, engaging 
in physically hazardous activities while under the influence of a substance, legal 
problems and social and/or family problems. Treatment of substance abuse typically is 
focused on social support systems and the individual accepting that there is a problem 
(ALLPSYCH Online, 2004). The most widely used treatment options are organizations, 
such as Alcoholics Anonymous (AA) and other rehabilitation programs, such as 
outpatient and inpatient treatment. Long-term care and follow-up are important in the 




Table 3.   Criteria for Substance Abuse (From: American Psychiatric Association, 
1994)  
A maladaptive pattern of substance use leading to clinically significant impairment or 
distress, as manifested by one (or more) of the following, occurring within a 12-month 
period:  
• Recurrent substance use resulting in a failure to fulfill major role obligations at 
work, school, or home (e.g., repeated absences or poor work performance related 
to substance use, substance-related absences, suspensions, or expulsions from 
school, neglect of children or household) 
• Recurrent substance use in situations in which it is physically hazardous (e.g., 
driving an automobile or operating a machine when impaired by substance use).  
• Recurrent substance-related legal problems (e.g., arrests for substance-related 
disorderly conduct).  
• Continued substance use despite having persistent or recurrent effects of the 
substance (e.g., arguments with spouse about consequences of intoxication, 
physical fights).  
Note: the symptoms have never met the criteria for substance dependence for this 
class of substance.  
Criteria for Substance Dependence 
A maladaptive pattern of substance use, leading to clinically significant impairment 
or distress, as manifested by three (or more) of the following. 
• Tolerance, as defined by either of the following: 
• A need for markedly increased amounts of the substance to achieve 
intoxication or desired effect 
• Markedly diminished effect with continued use of the same amount of 
the substance.  
• Withdrawal, as manifested by either of the following: 
• The characteristic withdrawal syndrome for the substance.  
• The same (or a closely related) substance is taken to relieve or avoid 
withdrawal symptoms. 
• The substance is often taken in larger amounts or over a longer period than was 
intended.  
• There is a persistent desire or unsuccessful efforts to cut down or control 
substance use.  
• A great deal of time is spent in activities necessary to obtain the substance (e.g., 
visiting multiple doctors or driving long distances), use of the substance (e.g., 
chain-smoking), or recover from its effects. 
• Important social, occupational, or recreational activities are given up or reduced 
because of substance use.  
• The substance use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have been caused or 
exacerbated by the substance (e.g., current cocaine use despite recognition of 
cocaine-induced depression, or continued drinking despite recognition that an 
ulcer was made worse by alcohol consumption). 
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An important component of the epidemiology of substance abuse is its pattern of 
comorbidities. A current article in Military Medicine recommended that abstinence or 
responsible alcohol use be encouraged as an intervention due to the comorbidity of 
anxiety, depression and PTSD as conditions known to increase alcohol use (Bray, 2010). 
However, according to recent literature, substance abuse is linked to other mental health 
disorders. In a study conducted on the relationship of combat experiences to alcohol 
misuse in soldiers returning from OIF, the authors found that soldiers that screened 
positive for alcohol misuse had significantly more mental health problems than those who 
had not deployed (Wilk, 2010). Substance abuse as a comorbidity of other disorders is 
not as commonly referenced in current literature as PTSD or anxiety disorders; however, 
this may be a limitation of diagnosis or comprehensive evaluation in research.  
D. PAST RESEARCH ON DEPRESSION AND SUBSTANCE ABUSE 
Epidemiological studies on substance abuse and depression look at the incidence 
and prevention of these disorders. Depression is currently a leading cause of disability 
globally and may have substantial long-term effects on individuals and society (World 
Health Organization, 2010). In addition, substance abuse is often a co-occurring mental 
health disorder. Since the start of OEF and OIF, a multitude of studies have been 
conducted that support the theory that combat operations lead to an increased probability 
of mental health disorders in returning veterans, thus increasing the demand for mental 
health utilization (Seal, 2009). Wilk et al. also found that deployments and combat 
exposure result in a greater incidence of depression and substance abuse, which further 
supports the findings of past research.  
The sustained and increased tempo of deployments to OEF and OIF have 
provided unequivocal evidence of increased rates of depression and substance use in 
military personnel. All of the current studies conducted on the prevalence of substance 
abuse and depression demonstrate consistency in methodology, sampling restrictions and 
time period of study. Common methods found in the current studies include using 
diagnostic codes (ICD-9 codes), screening tools to indentify persons with specific 
disorders, and diagnostic interviews conducted either by a clinical specialist or by trained 
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individuals (Tanielian, 2008). Most studies clearly focus on the time periods covering 
OEF and OIF. Lengths of the current studies typically target post deployment time frames 
of three months, six months and one year post deployment, and focus primarily on OEF 
and OIF. The 2008 RAND report titled Invisible Wounds of War, provides an excellent 
extensive and comprehensive review of the prominent current literature on the prevalence 
of PTSD, depression and traumatic brain injury amongst the military population. 
Although the focus for this thesis is on depression and substance abuse, the RAND report 
is a valuable source of current research and thinking regarding the impact of mental 
health illness amongst military personnel that have deployed in OEF and OIF. 
Current studies addressing depression in current and former active duty, reserve 
and National Guard members use similar screening tools that have been tested and 
validated to assess the incidence of depression and substance abuse. The majority of 
current studies use survey methods focusing primarily on Army and Marine active duty 
personnel. Typical survey time frames are between 2004 and 2007 with prevalence rates 
identified at the three and 12-months time points (Thomas, 2010). Additionally, many of 
the studies suggest that three and 12 months are widely accepted points in time where 
deployed personnel will manifest mental health issues or begin to seek treatment or be 
referred to treatment. The tools used for many of the studies for depression are based off 
of the DSM-IV and include a nine-item Patient Health Questionnaire (PHQ-9) (Kline, 
2010), and the Beck Depression Inventory (BDI-II) (Bray, 2010; Ferrier-Auerbach, 
2009). Substance abuse tools used include the two-item Conjoint Screen for Alcohol 
(TICS) (Thomas, 2010; Wilk, 2010), four item questions adopted from the National 
Council on Alcohol Consumption Questions and two item questions indicating alcohol 
use (Ferrier-Auerbach, 2009) and the Alcohol Use disorders Identification test (AUDIT), 
a ten-item self-reported measurement screen (Reger, 2009).  
The study conducted by Bray et al. looked at findings from the 2008 Department 
of Defense (DoD) Health Related Behaviors Among Active Duty Military Personnel 
Surveys (HRBS) to analyze trends observed in various mental health issues. The results 
of the 2008 HRBS were compared to previous HRBS studies going back to 1980. Bray et 
al. note that the 2008 survey permits them to look at the total force, including personnel 
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who have deployed to OEF and OIF, thus giving some insight into health related 
behaviors since the start of OEF and OIF. To capture the combat deployment measure, 
they assessed questions to specifically place personnel in three categories: “those who 
had been combat deployed and served in OEF and OIF, those who had been combat 
deployed to other theaters, and those who had not been combat deployed” (Bray et al., 
2010) since September 11, 2001. For the 2008 HRBS, they took a random sample of 64 
worldwide installations then randomly selected 600 personnel, regardless of deployment 
status, at each of the installations to take the 2008 HRBS. Their key measures used 
multiple definitions to measure substance use and mental health. The measures for 
substance abuse included subcategories, such as alcohol, drugs and cigarettes. For mental 
health measures, they used stress, anxiety, depression, PTSD and suicidal ideation and 
attempts. The specific defining key measures for the study are similar to the same tools 
found in other studies. Regarding alcohol and depression, they found that heavy alcohol 
use was steady from 1988 to 1998, but increased from 15 percent in 1998 to 20 percent in 
2008. They also found that for depression and anxiety, real changes occurred from 2005 
to 2008, but the need for further PTSD evaluation increased 12.4 percent for those 
deployed to OEF and OIF versus 8.2 percent for those not deployed.  
Several studies looked at the pre-deployment and post-deployment time frame to 
better understand and evaluate mental health relating to post-deployment. Thomas et al. 
(2010) looked at the broad effects of combat deployments in the first year after returning 
from Iraq and Afghanistan. Focusing on three months and 12 months post-deployment 
time periods, they examine the prevalence of rates of depression, PTSD and evaluate 
alcohol misuse, which is considered a comorbid condition in this study. Similar to the 
majority of studies using survey-based analysis, they use many of the same tools 
previously discussed to define their key indicators of PTSD, depression, functional 
impairment, alcohol misuse, aggressive behaviors and demographics. Between 2004 and 
2007, they anonymously surveyed 18,305 personnel from four active component Infantry 
Brigade Combat Teams and two National Guard Infantry Brigade Combat Teams, out of 
which 13,226 were identified as veterans of OIF, and therefore, used for analysis. One of 
the objectives of the study was to compare the post-deployment rates of the Active Duty 
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components and National Guard. The analysis included simple frequency, descriptive 
statistics and logistic regression to determine whether differences were observed from the 
three months and 12 months post deployment time frames. They found the active duty 
component personnel had rates of depression at the three months post-deployment return 
date estimated at 16 percent, and 11.5 percent for the National Guard. Additionally, they 
found that alcohol misuse was 12.4 percent at the three months post-deployment date for 
the active duty component personnel, and 14.5 percent for National Guard. The 12 
months time frame was 9.9 percent for active duty component personnel, and 15.0 
percent for National Guard.  
Another study conducted by Kline et al. assessed the effects of prior deployments 
in OIF on New Jersey Army National Guard members preparing for deployments to Iraq. 
Kline et al. specifically “compared the health status of soldiers with previous OEF and 
OIF deployments with that of soldiers experiencing their first deployment…compared the 
present survey with New Jersey’s pre-deployment health assessments on identification 
rates of key mental health problems.” Their study consisted of 2,543 anonymous pre-
deployment surveys collected in 2008. The original number surveyed was 2,665, 122 
were omitted due to startup delays, non-completes and poor data quality. In addition to 
the survey, they collected “de-identified” health data from the New Jersey Department of 
Military and Veterans Affairs (DMAVA), which provided relevant pre-deployment 
medical assessment information. The soldiers were placed into two groups; one consisted 
of those who had no prior OEF and OIF deployments and one consisting of those who 
had deployed one or more times to OEF and OIF. The study measured PTSD, depression, 
alcohol use and other drugs, other mental health, physical health and reports of mental 
health symptoms. Using logistic regression, they found that deployed soldiers were three 
times more likely than non-deployed soldiers to screen positive for major depression, and 
to meet DSM-IV criteria for alcohol dependence (Kline et al., 2010). The survey 
comparison to DMAVA data revealed lower results in mental health conditions. The 




percent (n=25) whereas the survey, sample size of 2,543 identified depression at 3.4 
percent (n=86) and for substance use problems DMVA identified 0.3 percent (n=8), the 
survey 7.2 percent (n=183).  
The study conducted by Wilk et al. focused on alcohol misuse in soldiers from 
Brigade Combat Infantry Teams during the first three to four months following OIF 
deployment. They anonymously surveyed soldiers from a large Army installation in 2006 
with an available population of 2,200. Out of the available soldiers, they received surveys 
from 1,221, identifying 1,120 who were OIF post-deployed and 1,080 who responded to 
alcohol related questions. The key dependent variable in the study was a positive screen 
for alcohol misuse as identified with the TICS tool. Four logistic models were used for 
analysis to evaluate the associations of reported combat exposure, demographics, unit 
cohesion and mental health problems. The overall findings according to Wilk et al. were 
that “one in four soldiers screened positive for an alcohol misuse problem three to four 
months post deployment to Iraq.” In addition to finding positive screening for alcohol 
misuse, they also noted that combat experiences were also strongly related to alcohol 
misuse problems. The authors comment that the positive combat relationship to alcohol 
misuse may be a result of the threatening nature of combat, and may be a reliable 
predictor of post-deployment alcohol misuse.  
The study conducted by Jacobson et al. (2008) focused specifically on pre and 
post deployment alcohol use amongst active duty and reserve component personnel. The 
study is uniquely different from other research in the fact that they look at all four 
branches of service, Army, Marine Corps, Navy and Air Force in the analysis. They use 
data from the Millennium Cohort Study covering the time frames from 2001 to 2006. 
Statistical analysis used in the study consisted of univariate and multivariate modeling to 
capture the associations of alcohol use. Outcome measures were heavy weekly drinking, 
binge drinking and alcohol related problems. Baseline and follow-up assessments were 
based on the validated tools, similar to previous research studies, of which further 
information can be found in the actual study. Their results are consistent with other 
research, finding that active duty personnel are more likely to have a higher prevalence of 
post-deployment drinking than those who have not deployed for all three of their 
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outcomes. Specifically, they found that Marine Corps personnel display a higher 
prevalence of new onset alcohol use out of the four services. Marine Corps percent of 
alcohol use as compared to the Air Force, which had the lowest prevalence are: heavy 
weekly drinking Marine Corps 7.3 percent, Air Force 3.7 percent; binge drinking Marine 
Corps 24.8 percent, Air Force 18.4 percent; < 1 drinking-related problem Marine Corps 
7.6 percent, and Air Force 2.3 percent (Jacobson et al., 2008). Reserve personnel with 
combat deployment were also found to have a higher likelihood of new onset alcohol use 
in all outcomes compared to deployed to non-combat exposure. The odd ratio for combat 
deployed were, heavy weekly drinking 1.63, binge drinking odds ratio 1.46 and alcohol-
related problems odd ratio 1.63. For the non-combat deployed reserve personnel, the odd 
ratios’ were heavy weekly drinking 1.09, binge drinking odds ratio 1.10 and alcohol-
related problems odds ratio 0.88. Additionally, the study found that personnel who had 
baseline symptoms of depression, PTSD or other mental health disorders were at an 
increased risk of a new onset alcohol-related problem. The authors of the study point out 
that “combat deployment in support of the wars in Iraq and Afghanistan was significantly 
associated with new-onset heavy weekly drinking, binge drinking, and other alcohol-
related problems among Reserve/Guard and younger personnel after return from 
deployment” (Jacobson et al., 2008). Again, this is consistent with previous studies. 
Milliken et al. conducted a longitudinal assessment study from 2005 to 2006 that 
was population based with a substantial initial cohort of 88,235 personnel returning from 
Iraq. They looked at two key time frames, the Post-Deployment Health Assessment 
(PDHA) immediately upon return from deployment and the Re-Assessment Post-
Deployment Health Assessment (PDHRA) conducted three to six months following 
return. Key measures for the study consisted of a positive screening for PTSD, major 
depression, alcohol misuse, other mental health problems and referral and use of mental 
health services (Milliken et al., 2007). To make comparisons with active duty 
components, they used odds ratios with 95 percent confidence intervals and x testing. 
Milliken et al. found that military personnel indicate more mental health issues on the 
PDHRA and on the PDHA. PDHA/PDHRA results for active duty personnel for 
depression went from 4.7 percent to 10.3 percent, and for reserve personnel 3.8 percent to 
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13.0 percent. According to their study, National Guard and Army reserve soldiers had 
similar results as active duty personnel, but reported higher rates of mental health 
problems as compared to active component soldiers. However, the precise nature of the 
higher rates is not clearly understood. Milliken et al. suggest that one reason for this 
observation is that at re-assessment, National Guard and Army Reserve soldiers are 
frequently beyond the DoD benefit window, and therefore, tend to report mental health 
problems more frequently.  
In general, most of the studies have made attempts to evaluate pre and post OEF 
and OIF deployment effects on the mental health of soldiers. The general consensus is 
that higher rates of depression and substance abuse occur in populations that have 
deployed to combat zones as compared to those that have not deployed. Another common 
trend in the current literature is that National Guard and Army reserve service members 
have higher rates of mental health disorders, such as depression and substance abuse as 
contrasted to their active service member counterparts. 
E. SHORT-COMINGS IN CURRENT STUDIES 
Recent literature consists of retrospective studies. Most of the studies use survey 
methods targeting Army and Marine soldiers, which make sense due to their exposure to 
combat situations, but Navy and Air Force are underrepresented in the literature. The 
majority of the current literature about substance abuse and depression is limited by 
survey methods and focus primarily on Army and Marine personnel. A couple of studies 
address the National Guard and reserve components, but they differ on sample selection. 
The vast majority of studies conclude that increased operational tempos in Afghanistan 
and Iraq increase the prevalence of depression and substance abuse for those who have 
deployed. One of the predominant weaknesses of current studies is a lack of diversity in 
sample selection. Although it is clear that many studies focus on Army and Marine 
personnel, they are not the only groups subject to deployment to combat regions. The 
Navy and Air Force have also been deployed to Iraq and Afghanistan, but are poorly 
represented in the current literature. The focus on Army and Marines makes it difficult to 
generalize about the other branches.  
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The common theme of the surveys also shows limitations in the accurate 
representation of samples. The majority of survey methods focus on self-reported 
outcomes to measure for mental health screening. Members may opt out and not take the 
survey or may not be truthful in response to survey questions as opposed to clinical 
diagnostics. A common acknowledgment of limitations in the literature is that active duty 
personnel may not be willing to divulge information for fear of being “labeled.” Fear of 
being labeled with a mental health disorder is a common theme in many studies and 
presents some barriers to measuring true mental health disorder prevalence. This method 
also poses a challenge for making generalized assumptions on the impact of deployment 
on military personnel.  
The screening tools used in most studies present limitations in making accurate 
assumptions. Although many of the tools have been validated, AUDIT, Beck Depression 
Inventory and TICS, for example, they are not diagnostic tools. Other tools used may not 
be as well defined and may lack appropriate validation. Thus, they may not be sufficient 
to capture diagnostic procedures accurately. Given the complicated nature of capturing 
the mental health and cognitive conditions associated with substance abuse and 
depression, the tools that have been used may inadvertently underestimate the true 
prevalence of these disorders.  
F. SUMMARY 
The current literature provides considerable insight into the prevalence of 
depression and substance abuse in the military population after completion of 
deployments to OEF and OIF. The mounting evidence in the literature supports the 
hypothesis that a sustained combat operation negatively affects the mental health of 
soldiers who have been deployed. The long-term implications and costs of increased 
utilization of healthcare services, prevention and better screening are clearly an important 
and vital aspect in addressing the mental health needs of military personnel, either active 
component, National Guard or reserve. The remainder of this thesis examines the effects 
of deployment length, and location on major depression and substance abuse affecting the  
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four branches of service, Navy, Marine Corps, Army and Air Force from fiscal years 
2001 to 2006, as well as discussion on the impact on reserve and National Guard. The 
inclusion of the four branches of service will further current literature.  
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III. DATA AND DESCRIPTIVE STATISTICS 
A. INTRODUCTION 
This chapter provides a description of the data and their different sources. Section 
B provides a description of the data sources and the agencies that provided the respective 
data. Section C describes the deployment data. Sections D and E provide sample 
descriptions and an explanation of how the data has been organized for the study and 
acknowledges the restrictions associated with the data files used in this study. Finally, 
section F summarizes the key points of the chapter. Additionally, in this chapter, the 
summary statistics are presented with demographics for substance abuse models and 
major depression models.  
B. DATA SOURCES 
The data for this thesis come from two main sources, TRICARE and Defense 
Manpower Data Center (DMDC). A random sample of active duty service personnel 
from the four service branches (Army, Navy, Marine Corps and Air Force) from 2001 to 
2006 is used for this study. The TRICARE Defense Eligibility Enrollment Reporting 
System (DEERS) data contains basic demographic and service information for each 
service members and are broken into nine files (four for the Army, two for the Air Force, 
two for the Navy and one for the Marine Corps), which are combined into four files for 
the respective branches of service for easier processing and for analysis. The TRICARE 
DEERS data files contain all the same variables for each respective data set model. 
TRICARE DEERS data was merged with the DMDC Contingency Tracking System 
(CTS) data, which contains information on the deployment characteristics for active duty 
service personnel from 2001 to 2006. To answer the research questions for this study and 
execute the models, two different data files were created to account for the variables of a 
diagnosis of substance abuse and major depression.  
 
 22
DEERS is a worldwide, computerized database of uniformed service members 
and their families (TRICARE, 2010). To be eligible for TRICARE benefits, active duty 
personnel and eligible family members must be registered in DEERS. Active duty 
personnel (sponsor) are automatically registered in DEERS for military benefits to 
include enrollment in TRICARE. TRICARE uses International Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnostic codes in TRICARE 
claims. The ICD-9 is a standardized classification system that allows physicians to code 
disease, injuries and cause of death by its etiology and anatomic location. The ICD-9 
diagnostic coding system is recognized nationally and internationally providing for 
standardization of disease classification and coding. Major depression ICD-9 codes used 
for this study are 296.2 (major depressive disorder, single episode) and 296.3 (major 
depressive disorder, recurrent episode). For substance abuse the ICD-9 codes used are 
291 (alcohol-induced mental disorders), 303 (alcohol dependency syndrome) and 305 
(nondependent abuse of drugs). 
The TRICARE data contains the main DEERS data that provides basic 
demographic information and diagnostic codes for substance abuse and major depression 
for the Army, Air Force, Navy and Marine Corps active duty service population from 
2001 to 2006. The Electronic Data Interchange Person Numbers (EDIPN)—personnel 
unique identifier—in the DEERS data files, connects all subsequent files together. Table 
4 shows the descriptive statistics for the data set variables for major depression and 






















Number of observations 776,709          52,344            6.74% 724,365          93.26% 777,447          18,484       2.38% 758,963              97.62%
Female 92,559            5,413              5.85% 87,146            94.15% 92,551            6,107          6.60% 86,444                93.40%
Male 684,150          46,931            6.86% 637,219          93.14% 684,896          12,377       1.81% 672,519              98.19%
Single 407,745          28,761            7.05% 378,984          92.95% 407,127          7,844          1.93% 399,283              98.07%
married 368,964          23,583            6.39% 345,381          93.61% 370,320          10,640       2.87% 359,680              97.13%
Army 383,428          26,794            6.99% 356,634          93.01% 383,977          9,178          2.39% 374,799              97.61%
Air Force 135,434          7,133              5.27% 128,301          94.73% 135,527          4,023          2.97% 131,504              97.03%
Marine Corps 107,648          6,074              5.64% 101,574          94.36% 107,688          1,796          1.67% 105,892              98.33%
Navy 150,199          12,343            8.22% 137,856          91.78% 150,255          3,487          2.32% 146,768              97.68%
Officer and Warrant Officer 95,940            1,840              1.92% 94,100            98.08% 96,078            1,526          1.59% 94,552                98.41%
Enlisted 680,769          50,504            7.42% 630,265          92.58% 681,369          16,958       2.49% 664,411              97.51%
White 521,479          36,961            7.09% 484,518          92.91% 522,002          12,753       2.44% 509,249              97.56%
Black 130,761          7,805              5.97% 122,956          94.03% 130,924          2,981          2.28% 127,943              97.72%
Hispanic 47,076            2,887              6.13% 44,189            93.87% 47,044            1,016          2.16% 46,028                97.84%
Asian 28,952            1,195              4.13% 27,757            95.87% 28,914            446             1.54% 28,468                98.46%
Other Race 48,441            3,496              7.22% 44,945            92.78% 48,563            1,288          2.65% 47,275                97.35%  
 
In addition to the basic information obtained from DEERS data, this study uses 
the TRICARE claims data merged with the CTS data to analyze the prevalence of major 
depression and substance abuse in the four branches of the military active duty 
population. The TRICARE data consists of four fundamental data sets containing 
outpatient data and inpatient data records.  
1. Inpatient Medical Records for Major Depression and Substance 
Abuse 
Inpatient is defined as a patient that receives care in an authorized institution and 
occupies a bed for receiving the necessary medical care. The minimum period of 
inpatient classification is 24 hours requiring a registration number and assignment of 
inpatient number (TRICARE Management Activity, 2006, p. 21). Active duty service 
personnel are authorized to receive care through military treatment facilities or authorized 
institutions. The primary route of care for active duty service personnel is a military 
treatment facility; however, if no facility is available or referral is necessary, service 
members are permitted to use authorized institutions. The data files relevant to inpatient 
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care are the standard inpatient data record (SIDR) and the TRICARE Encounter Data—
Institutional (TEDI). The SIDR data contains records of active duty service personnel 
treated as inpatients at a military treatment facility. TRICARE encounter data consists of 
data for all care received and delivered under contract (TRICARE Management Activity, 
2006, p. 37). TEDI contains data that may describe beneficiary identification, provider 
identification, and health information, such as place and type of service, diagnosis and 
treatment-related data, units of service and financial information. Each record for the 
TEDI identifies a single treatment record for active duty personnel treated in an 
authorized institution other than a military treatment facility.  
2. Outpatient Medical Records for Major Depression and Substance 
Abuse 
TRICARE defines an outpatient as a patient who has not been admitted to a 
hospital or other authorized institution as an inpatient (TRICARE Management Activity, 
2001, Appendix A, p. 44). Active duty service personnel are authorized to receive care 
through military treatment facilities or authorized civilian professional medical services 
for outpatient care. The primary route of care for active duty service personnel is a 
military treatment facility. According to TRICARE, eligible service members are 
permitted to seek care outside the military treatment facility if required medical services 
are not available in the military treatment facility or if there is a lack of adequate support 
services available to the service member. Referral from the primary care coordinator is 
required and noted in the service member’s DEERS and Composite Health Care system 
(CHCS) records (TRICARE Management Activity, 2006, p. 38).  
Non-institutional care for major depression and substance abuse data found in the 
TEDN2 data set data consists of care received by active duty service personnel from 
authorized providers for treatment. 
The four data files from TRICARE (SADR, SIDR2, TEDI2, TEDN2) are 
instrumental in the merge process to identify individuals diagnosed with substance abuse 
and major depression. Merging the TRICARE data files creates major depression and  
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substance abuse variables with the unique EDIPN, which permits this data to be merged 
with the Defense Manpower Data Center data to create a working analytical file for the 
models in this study.  
C. DEPLOYMENT DATA FROM DEFENSE MANPOWER DATA CENTER  
Defense Manpower Data Center (DMDC) data contains the Contingency 
Tracking System (CTS) data, which provides information on active duty service 
personnel deployment characteristics. A major focus of this study is the effects of 
deployment location and length on major depression and substance abuse across the four 
branches of service. The DMDC CTS data contains military specialty codes (MOS), 
deployment information for location and number of deployments from 2001 to 2006. 
Using the DMDC CTS data, it is possible to track personnel with multiple deployments 
and pair it with the TRICARE DEERS data for initial diagnosis date. For the purpose of 
this study, deployment focus is on Operation Enduring Freedom (OEF) and Operation 
Iraqi Freedom (OIF). Deployment locations are categorized into the following three 
categories: (1) Iraq or Afghanistan, (2) classified or unknown locations, and (3) any other 
known countries under OEF and OIF. Navy personnel models have additional variables 
that account for ship versus shore deployments. Total days of deployment (from all 
deployments) are categorized into the following, 1 to 120 days, 121 to 180 days, 181 to 
365 days and greater than 365 days. To evaluate deployment frequency, deployments is 
categorized by number of deployments, one, two and three or more to any location under 
OEF and OIF and Afghanistan or Iraq. 
The DMDC CTS data set was merged with the DEERS data, which yields two 
working analytical files for model analysis.1 Since major depression and substance abuse 
are the two major dependent variables, two analytical data files are required to answer the 
research questions. The merged dataset for major depression consists of 808,885 
observations, of which 18,766 are diagnosed with major depression. The dataset for  
 
                                                 
1 Dennis Mar was the programmer that worked to create the base analytical files used for the 
foundation of this thesis. 
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substance abuse contains 808,135 observations for all active duty service personnel, out 
of which 52,869 are identified with a diagnosis of substance abuse. All duplicate 
observations with missing values are dropped. 
D. DATA SAMPLES 
To perform the analysis on the research questions for this thesis, the merged 
TRICARE DEERS and DMDC data is sub-organized into eight separate working 
analytical data files. Two files each for the Army, Marine Corps, Navy and Air Force. 
Each of the sub-organized data files contains the EDIPN, which is the unique personnel 
identifier that links all data. Those files missing EDIPN and date of birth were dropped 
from the data files. The purpose of the eight data files chiefly permits analysis of the 
research questions for the four respective branches of active duty service Army, Marine 
Corp, Navy and Air Force. Four of the working analytical data files are for analysis of the 
dependent variable of major depression diagnosis for each branch of active duty service 
personnel from 2001 to 2006, and four of the data files are for the dependent variable of 
substance abuse diagnosis for each branch of the active duty service personnel from 2001 
to 2006. Each dataset contains the variables obtained by merging the TRICARE DEERS 
and DMDC data for demographics, diagnosis, year, military rank, specialty and 
deployment locations and length.  
E. RESTRICTIONS 
One restriction in this study was missing information in the TRICARE and 
DMDC data. There was a significant number of missing EDIPNS and missing dates of 
birth within the TRICARE DEERS data from 2001 to 2006. The missing EDIPNs and 
dates of birth affect the size of the sample since they were omitted from the study. A 
more precisely estimated analysis may have been possible with more observations. In 
addition to the missing dates of birth and EDIPNS, there were some observations with 
missing demographic information; however, they were not as significant. These 
observations are clearly omitted from the analysis.  
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A second restriction is the omission of the officer population in this study. The 
focus of this study is on the enlisted population from 2001 to 2006 deployed in the Global 
War on Terrorism (GWOT). Inclusion of officer observations would provide a more 
comprehensive view of the effects of major depression and substance abuse rates on 
deployment characteristics. However, since the focus is on the effects on enlisted 
personnel in the four active duty service branches, officers are not factored into the 
models for analysis. 
F. SUMMARY 
Two main analytical files, one for major depression and one for substance abuse 
were generated from the merged data files from TRICARE and DMDC. Out of the two 
main analytical files, eight sub-data files were created to perform analysis on the research 
questions in this thesis. Each of the eight sub-data files were divided into four 
independent working data files for the Army, Marine Corps, Navy and Air Force.  
Four of the active duty service data files have the dependent variables of major 
depression while the other four have substance abuse. The separate data files permits 
analysis of the three research questions. Each file contains all respective variables. 
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IV. ANALYTICAL METHODOLOGY 
A. INTRODUCTION 
This chapter outlines the analytical methodology and the models used to perform 
the analysis for this thesis. Section B contains the research questions for this thesis and 
section C describes the research hypotheses. Section D discusses the empirical model for 
this thesis and provides details of the independent and dependant variables used. Finally, 
section E summarizes the key points of the chapter. 
Additionally in this chapter, the summary statistics are presented with 
demographics for the substance abuse models and major depression models.  
B. RESEARCH QUESTIONS 
The three research questions analyzed in this thesis focus on the diagnosis of 
major depression and substance abuse and the role this diagnosis plays in the Global War 
on Terrorism (GWOT). The research questions are described below.  
• What are the rates of major depression and substance abuse amongst all 
active duty enlisted personnel and how do the rates differ by service and 
deployment?  
• How does deployment location (specifically, Iraq and Afghanistan) affect 
the probability of being diagnosed with major depression and substance 
abuse? 
• Is there a cumulative effect of deployments (i.e., frequency of separate 
tours and total days in theater) on major depression and substance abuse? 
The remainder of this chapter focuses on the analytical methodology and models 
used to analyze the research questions presented in this thesis.  
C. RESEARCH HYPOTHESES 
One of the main objectives of this thesis is to analyze the rates of major 
depression and substance abuse in the active duty population. Specifically, how the rates 
of these two mental health conditions differ across the four different branches of service. 
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Previous research indicates that deployment to Operation Enduring Freedom (OEF) and 
Operation Iraqi Freedom (OIF) do indeed place active duty personnel at higher risk for 
mental health disorders. The author hypothesizes that the rate of major depression and 
substance abuse will increase for active duty enlisted personnel in the four service 
branches, as the result of OEF and OIF. The rate of major depression or substance abuse 
will mostly likely be higher for the Army and Marine Corps active duty enlisted 
personnel who have deployed to OEF and OIF than it will be for the Navy and Air Force. 
However, also hypothesized is that Navy and Air Force personnel deployed to OEF and 
OIF will also have a higher probability of being diagnosed with major depression and 
substance abuse as compared to those who have not been deployed to OEF or OIF. Both 
Army and Marine Corps personnel are more likely to be deployed to combat locations 
and in greater numbers. Navy and Air Force enlisted personnel are clearly deployed to 
OEF and OIF combat operations, but in smaller numbers and typically not as front line 
combat operations. However, Navy and Air Force personnel still experience the stressors 
associated with deployment to combat operations. Therefore, the author expects that they 
will have a higher probability of major depression and substance abuse diagnosis when 
compared to personnel who have never deployed to OEF and OIF operations. 
Additionally, it is suspected that for Navy personnel who have deployed, the probability 
of diagnosis might be higher because certain Navy ratings, such as medical personnel, 
often deploy with Marine Corps units.  
Next, the author hypothesizes that the deployment location, specifically to Iraq, 
Afghanistan, or classified or unknown locations will increase the probability of being 
diagnosed with major depression and substance abuse relative to deployment to other 
locations. Lastly, also hypothesized is that there will be cumulative effect of deployments 
to OEF and OIF on major depression and substance abuse. The nature of deployment to 
combat locations poses stressors to military personnel. Threat of death, injury, witnessing 
the death or major injury of fellow personnel, along with the inherent stress of combat 
warfare, places deployed men and women at a risk for being diagnosed with major 
depression or substance abuse. Multiple deployments to OEF and OIF, the author  
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hypothesizes, will increase the probability of active duty service personnel being 
diagnosed with major depression or substance abuse. The cumulative effects of these 
deployments will positively affect the probability of being diagnosed.  
To answer the three research questions and analyze the hypotheses regarding the 
effects of major depression and substance abuse amongst the enlisted population across 
the four services, the author implements descriptive and multivariate analyses. To isolate 
the effects of major depression and substance abuse, the multivariate analysis involves 
separate regressions conducted for each respective branch of service. The multivariate 
analysis for each branch of service uses the same models. The results and findings are 
discussed later in this thesis.  
D. EMPIRICAL MODEL  
The empirical model used for analysis is Non-Linear Probability, probit 
regression with binary indicators. Probit regression is used to perform the analysis and to 
estimate the effects of deployment location and duration (total days deployed and 
frequency of deployments) of deployment. The dependent variable, major depression or 
substance abuse, has the value of one or zero. A value of one represents a person being 
diagnosed with major depression or substance abuse, zero otherwise. Models are 
estimated separately for the Army, Marine Corps, Navy, and Air Force, and separately 
for each condition. In other words, each model described below is estimated eight times 
for the two different conditions and the four difference services. 
1. Independent Variables 
The base model used for probit regression is described below: 
Pr(y=1|x) = β0 + β1X1 +β2X2  
X1 = Deployment characteristics 
X2 = Service and demographic characteristics 
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The vector of regressors X1, which are assumed to influence the outcome Y, 
contains the key variables for deployment characteristics in the probit model. 
Deployment location, duration, and type of deployment (ship or shore for Navy) are 
different depending on the branch of service. Therefore, they are slightly different for the 
Navy model.  
The vector of regressors X2, which are assumed to influence the outcome Y, 
contains the variables for demographic and service characteristics in the probit model. 
Unlike the vector of X1, these control variables do not change within the models. They 
remain constant through all regression models and for each branch of service.  
a. Deployment Characteristics  
The deployment characteristics contain the key variables of deployment 
used in the probit models. The key variables of interest are deployment locations, type of 
deployment (ship or shore) and duration of deployments (i.e., frequency of separate tours 
and the total days deployed in theater), which are described further below.  
(1) Effect of Deployment Location. For the first model, ever- 
deployed location is used to estimate the effect of being diagnosed with major depression 
or substance abuse. Ever-deployed location is represented by an individual who has ever 
deployed to a location prior to a diagnosis of major depression or substance abuse from 
2001 to 2006. The key variables used are binary variables of ever deployed under any 
OEF and OIF location, ever deployed to Iraq and Afghanistan, ever deployed to classified 
or unknown location, and ever deployed to shore (Navy specific). The location variables 
for the third model represent the frequency of deployments to any location under OEF 
and OIF and Afghanistan or Iraq. The key variables used are deployed only once, twice, 
and three or more times to any location under OEF and OIF and deployed to Iraq or 
Afghanistan only once, twice and three or more times. The reference group for the 
deployment location is those individuals who have not deployed. The expected findings 
are that individuals who have ever deployed under OEF and OIF will have a higher 
probability of being diagnosed with major depression or substance abuse.  
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In addition to the deployment location, the model also includes 
whether the service member is deployed ashore or on ship. This ship/shore indicator is 
only included in the Navy models. The reference group is those individuals who have 
ship deployments. The author anticipates that Navy personnel who have shore 
deployments will be more likely to have a diagnosis of major depression or substance 
abuse due the increased threats that they will encounter on shore deployments as opposed 
to shipboard deployments. 
(2) Deployment Duration. The second model focuses on the 
effect of cumulative days of deployment on mental health readiness. Deployment 
duration consists of variables delineating total days deployed from all tours. For a person 
with only one tour, this represents the total days from that particular deployment. For a 
person with multiple tours, this represents the summation of all days from all tours For 
ease of interpretation, the author further categorizes total days into the following: 1 to 
120 days deployed, 121 to 180 days deployed, 181 to 365 days deployed, and 366 or 
more days deployed. Location of deployment is included in the model, consists of the 
ever-deployed variables to Iraq or Afghanistan and ever deployed to classified or 
unknown locations. The reference group is individuals who have no deployments. The 
expectation is that individuals who have the greatest number of days deployed will be 
more likely to have a diagnosis of major depression or substance abuse. 
(3) Deployment Frequency. For the third model, the focus is 
analyzing the effect of frequency of separate deployments on mental health readiness. 
The key variables used are binary variables categorized as, deployed only once, twice, 
and three or more times under any OEF and OIF location and deployed to Iraq or 
Afghanistan only once, twice, and three or more times. In addition to model three, the 
author includes a comparison, 3.a, which includes total days deployed as a continuous 
variable to show the effects of frequency of deployments when total days is held 
constant. The reference group is individuals who have not been deployed. The 
expectation is that individuals who have the most deployments will be more likely to 
have a diagnosis of major depression or substance abuse. 
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b. Service Characteristics  
Military Occupational Specialty (MOS) codes specify what a military 
member’s occupation or job is within the given branch of service. An MOS will differ 
across the four service branches since the services code jobs differently. For the Marine 
Corps and the Army, the term military occupation code represents the specific job title 
and job function. The Navy uses a system to specify jobs called the Naval Enlisted 
Classification (NEC), and the Air Force uses a system termed Air Force Specialty Codes 
(AFSC). To ensure consistency for model analysis, MOS were categorized in specific and 
measurable binary variables. Although each branch of service does have its own military 
occupational code, they can be categorized to provide the consistency needed to perform 
analysis. The categories used are as follows: combat arms, combat support, combat 
service support, aviation, medical, and other MOS. Not all branches have observations 
for each category and some categories are merged due to the small number of 
observations. For analysis, combat arms is the reference group.  
Pay grade is the second service specific characteristic that remains 
consistent throughout the models. Pay grade represents observations categorized into 
binary variables for enlisted personnel. The categories used for this analysis are E–1 to 
E–3(one variable), E–4, E–5, E–6, and E–7 to E–9 (one variable).The variable E–7 to E–
9 is used as the reference group in all models.  
c. Demographic Characteristics 
The demographic characteristics used in the probit models consist of age, 
gender race, marital status, and fiscal year variables, which do not change through the 
course of the models. 
(1) Age. The age variable is a continuous variable and is the 
age of the individual at the time of diagnosis with major depression or substance abuse. 
Any missing age observations take on the average of the age variable from non-missing 
observations. 
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(2) Gender. Gender is a binary variable that represents male or 
female observations. The variable used in analysis is female, which takes on the value of 
one. The reference group for analysis in all models is male. 
(3) Race. Race variables consist of white, black, Hispanic, 
Asian, and others where each respective race variable takes on the value of one. The 
reference group for analysis in all models is the variable white. 
(4) Marital Status. The marital status variables represent 
whether an individual is married or single. The variable single, which takes on the value 
of one, is used in all models. Therefore, the reference group is married for all models.  
(5) Fiscal Year. The fiscal year is a binary variable that 
represents the years FY01, FY02, FY03, FY04, FY05, and FY06, and is intended to 
capture the macro trend in the two conditions over the years. The reference year for 
analysis in all models is FY01. 
The pay grade service characteristics and all demographic 
characteristic remain constant through all of the models, unlike the key deployment 
variables of interest. 
E. SUMMARY 
This chapter described the methodological approach to be used for multivariate 
analysis, as well as the prevalence of major depression and substance abuse. The four 
models combined with descriptive statistics were used to answer the research questions 
presented in this thesis. Descriptive statistics were evaluated to determine the overall 
probability of being diagnosed with major depression or substance abuse, which revealed 
that major depression rates were highest amongst Air Force personnel, while substance 
abuse rates were highest amongst the Navy enlisted. In addition, probit analysis models 
established the probability of enlisted personnel being diagnosed with major depression 
or substance abuse in the four branches of service. The results of the models described in 
this chapter are discussed in the next chapter. 
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V. ANALYSIS RESULTS  
A. INTRODUCTION 
This chapter outlines the results of the descriptive statistics and the four probit 
models used to analyze the effects of deployment on the probability of being diagnosed 
with major depression or substance abuse. The results are compared across the Army, 
Marine Corps, Air Force and Navy to examine how the effects of deployment location 
and duration differ. Section B restates the research questions for this thesis. Sections C 
and D of this chapter discuss the descriptive statistics analysis and show the findings for 
the rate of diagnosis across the services. Section E presents the multivariate probit 
analysis and the findings across the four branches of service for major depression and 
substance abuse. Finally, section F summarizes the key points and findings of the chapter.  
B. RESEARCH QUESTIONS 
The three research questions analyzed in this thesis focus on the diagnosis of 
major depression and substance abuse and the role these diagnoses have on the Global 
War on Terrorism (GWOT). The research questions are described below.  
• What are the rates of major depression and substance abuse amongst all 
active duty enlisted personnel and how do the rates differ by service and 
deployment?  
• How does deployment location (specifically, Iraq and Afghanistan) affect 
the probability of being diagnosed with major depression and substance 
abuse? 
• Is there a cumulative effect of deployments (i.e., frequency of separate 
tours and total days in theater) on major depression and substance abuse? 
The remainder of this chapter focuses on the analytical methodology and models 
used to analyze the research questions presented in this thesis.  
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C. DESCRIPTIVE STATISTICS ANALYSIS 
The purpose of this section is to first describe and analyze any trends in 
observations within the sample populations of major depression and substance abuse 
across the Army, Marines, Navy, and Air Force. The first section provides the basis for 
further analysis and contains descriptive statistics for the variables used for regression 
analysis. The second part of this section analyzes the rate of major depression and 
substance abuse across the four branches of service.  
1. Descriptive Statistics for the Major Depression Sample Population 
Table 5 shows the descriptive statistics for deployment characteristics of location 
and duration of the major depression population across all four branches of service. The 
population sample comprises those service members who have at any time been deployed 
under OEF and OIF and called in this paper ever deployed under OEF and OIF, and 
represents the highest percentage of the population for location with the exception of the 
Navy. For the Navy, being deployed to classified or unknown locations represents the 
second largest percentage, 28.3 percent of the deployment location characteristics. 
Frequency of deployments represents the average number of deployments specified by 
never being deployed, deploying once, twice, or three or more deployments. Frequency 
of first deployments for the Marines, Navy, and Air Force tends to be highest, and then 
decreases as frequency of deployments increase. For the Army sample population, the 
trend is different, three or more deployments represent the highest percentage in the 
sample with first deployments representing the smallest percentage of deployments. Days 
deployed 1 to 120 is the largest percentage for duration of deployment across all four 
services. This trend, when compared with the average number of deployments, is 
consistent considering that first deployments represent the highest percentage in the 





Table 5.   Descriptive Statistics of Deployment Characteristics for Major Depression 
Samples of the Four Branches of Service 
Major Depression Deployment 
Characteristics 
Army Marines Navy Air 
Force 
Sample Size 334,871 98,808 134,734 112,956
Location of OEF/OIF Deployment 
History         
Ever Deployed under OEF/OIF 22.4% 24.7% 35.1% 37.9% 
Ever Deployed to Afghanistan or Iraq 12.3% 8.9% 1.1% 5.7% 
Ever Deployed to Classified or Unknown 
Location 2.4% 6.0% 28.3% 11.7% 
Ever Deployed to Shore     28.4%   
Frequency of Deployment     
Not Deployed 77.6% 75.3% 64.9% 62.1% 
Deployed Once 8.2% 11.5% 20.9% 18.8% 
Deployed Twice 4.7% 7.1% 11.1% 11.3% 
Deployed Three or More Times 9.5% 6.1% 3.1% 7.7% 
Not Deployed to Afghanistan or Iraq 88.5% 91.3% 98.9% 94.7% 
Deployed Afghanistan or Iraq Once 3.3% 3.8% 0.6% 2.7% 
Deployed Afghanistan or Iraq Twice 3.1% 2.2% 0.3% 1.8% 
Deployed Afghanistan or Iraq Three or 
More  5.2% 2.6% 0.1% 0.8% 
Not Deployed to Classified Location 98.0% 95.5% 72.3% 90.1% 
Deployed to Classified Location Once 0.8% 2.0% 16.5% 4.5% 
Deployed to Classified Location Twice 0.5% 1.4% 8.9% 2.8% 
Deployed to Classified Location Three or 
More Times 0.8% 1.1% 2.3% 2.6% 
Categories of Total Days Deployed     
Days Deployed 0 (not deployed) 75.2% 73.7% 64.0% 61.4% 
Days Deployed 1 to 120 22.6% 24.9% 35.3% 38.0% 
Days Deployed 121 to 180 0.2% 0.2% 0.2% 0.2% 
Days Deployed 181 to 365 1.1% 0.8% 0.5% 0.2% 
Days Deployed 366 Plus 1.0% 0.4% 0.1% 0.1% 
Total Days of Deployment     
Total Days Deployed  579 345 226 206 
Total Days Deployed to Afghanistan or Iraq 397 282 223 172 
Total Days Deployed to Classified Location 127 164 199 129 
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Table 6 shows the descriptive statistics of deployment characteristics for location 
and duration for the substance abuse sample population across all four branches of 
service. Those who were ever deployed under OEF and OIF ranges from 22.7 percent 
(Army) to 37.9 percent (Air Force). For the Army sample, those who were ever deployed 
to Afghanistan or Iraq (12.3 percent) is the largest percentage for this category; whereas, 
the trend for the Marines, Navy, and Air Force, for those who were ever deployed to a 
classified or unknown location, shows the largest percentage for deployment history by 
location. Frequency of deployment is highest for first deployments for the Marines, 
Navy, and Air Force. Subsequent frequency of deployments decreases. However, for the 
Army, the trend in frequency of deployments is greatest when deployed three or more 
times. For the Army, days deployed 1 to 120 is 22.9 percent of the sample population. 
Being deployed more than 365 days for the Army is 1.0 percent, which is much greater 
than the other three services for deployments greater than 365 days (Marines -0.4 percent, 
Navy -0.1 percent, and Air Force -0.1 percent). This may be an indication of more 
frequent or longer deployment for Army personnel.  
Deployment characteristic descriptive statistics for major depression and 
substance abuse trends are very similar for each sample. The trends for both diagnoses 
show, those who were ever deployed under OEF and OIF is greatest across all branches.  
Deployment duration by total days of deployment is consistent for both sample 
populations.  The percentage of the populations for days deployed across all branches is 
highest for 1 to 120 days of deployment with days of deployment of 181 to 365 days 








Table 6.   Descriptive Statistics of Deployment Characteristics for Substance Abuse 
Samples of the Four Branches of Service 
Substance Abuse Deployment 
Characteristics  
Army Marines Navy Air 
Force 
Sample Size 334,434 98,778 134,711 112,846 
Location of OEF/OIF Deployment 
History         
Ever Deployed under OEF/OIF 22.7% 24.9% 35.3% 37.9% 
Ever Deployed to Afghanistan or 
Iraq 12.6% 9.0% 1.1% 5.7% 
Ever Deployed to Classified or 
Unknown Location 2.4% 6.0% 2.8% 11.8% 
Ever Deployed to Shore     28.4%   
Frequency of Deployment     
Not Deployed 77.3% 75.1% 64.7% 62.1% 
Deployed Once 8.3% 11.7% 20.9% 18.9% 
Deployed Twice 4.7% 7.2% 11.2% 11.4% 
Deployed Three or More Times 9.7% 6.1% 3.1% 7.6% 
Not Deployed to Afghanistan or Iraq 88.2% 91.2% 99.0% 94.7% 
Deployed Afghanistan or Iraq Once 3.4% 3.8% 0.6% 2.6% 
Deployed Afghanistan or Iraq Twice 3.1% 2.3% 0.3% 1.8% 
Deployed Afghanistan or Iraq Three 
or More  5.3% 2.6% 0.1% 0.8% 
Not Deployed to Classified Location 98.0% 95.6% 72.1% 90.1% 
Deployed to Classified Location 
Once 0.8% 2.0% 16.5% 4.5% 
Deployed to Classified Location 
Twice 0.4% 1.3% 9.0% 2.8% 
Deployed to Classified Location 
Three or Times 0.8% 1.0% 2.4% 2.6% 
Categories of Total Days Deployed     
Days Deployed 0 (not deployed) 74.8% 73.4% 63.8% 61.4% 
Days Deployed 1 to 120 22.9% 25.1% 35.4% 38.0% 
Days Deployed 121 to 180 0.2% 0.2% 0.2% 0.2% 
Days Deployed 181 to 365 1.1% 0.8% 0.5% 0.2% 
Days Deployed 366 Plus 1.0% 0.4% 0.1% 0.1% 
Total Days of Deployment     
Total Days Deployed  578.8 344.5 226.0 205.1 
Total Days Deployed to Afghanistan 
or Iraq 396.8 281.8 223.5 170.8 
Total Days Deployed to Classified 
Location  126.2 166.3 199.3 127.5 
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a. Service Characteristics 
Table 7 shows descriptive statistics for Military Occupational Service 
Codes (MOS) and rank for the major depression sample population for all four services.  
Table 8 is the descriptive statistics for the substance abuse sample population. Combat 
arms and combat support service tend to represent the highest percentage of the sample 
population for the Army and Marines.  This would be an expected finding since both 
services tend to have more personnel who fall into these categories.  The Navy’s highest 
percentage of representation is within the Other MOS category while the Air Force has 
combat service support, at 76.8 percent as the highest representation in the sample.  The 
sample population tends toward E–1 to E–3 representing the highest number of the 
population with E–7 to E–9 the lowest.  Of course, this tendency is entirely in line with 
active duty military structures showing higher percentages of lower ranking enlisted and 
lower percentages of higher ranking enlisted.  
 
Table 7.   Descriptive Statistics of Service Characteristics for Major Depression 
Samples of the Four Branches of Service 
Major Depression Service 
Characteristics 
Army Marines Navy Air 
Force 
Sample Size 334,871 98,808 134,734 112,956 
Military Occupational Specialty         
Combat Arms 27.7% 37.0% 4.6% 10.4% 
Combat Support 10.3% 16.1% 9.3% 0.2% 
Combat Service Support 25.4% 26.9% 5.4% 76.8% 
Aviation 0.0% 14.6% 3.3% 0.0% 
Medical 9.7% 0.1% 2.9% 0.4% 
Other MOS 26.8% 5.4% 74.5% 12.2% 
Rank         
E1-E3 34.1% 62.0% 38.8% 32.8% 
E4 28.7% 17.0% 19.9% 18.5% 
E5 17.7% 10.9% 20.5% 22.9% 
E6 11.3% 5.6% 13.5% 14.3% 
E7-E9 8.2% 4.4% 7.4% 11.5% 
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Table 8.   Descriptive Statistics of Service Characteristics for Substance Abuse 
Samples of the Four Branches of Service 
Substance Abuse Service Characteristics
Army Marines Navy Air 
Force 
Sample Size 334,434 98,778 134,711 112,846
Military Occupational Specialty*     
Combat Arms 27.9% 37.2% 4.6% 10.3% 
Combat Support 10.4% 16.2% 9.3% 0.2% 
Combat Service Support 25.4% 26.9% 5.4% 76.7% 
Aviation 0.0% 14.6% 3.3% 0.1% 
Medical 9.8% 0.1% 2.9% 0.4% 
Other MOS 26.6% 5.2% 74.6% 12.4% 
Rank         
E1-E3 34.0% 62.2% 38.8% 32.7% 
E4 28.8% 16.9% 20.0% 18.7% 
E5 17.7% 10.9% 20.4% 22.9% 
E6 11.3% 5.6% 13.5% 14.2% 
E7-E9 8.2% 4.4% 7.3% 11.5% 
b. Demographic Characteristics 
Demographic characteristics encompass race, gender, marital status, and 
average age of the sample population for major depression and substance abuse.  Tables 9 
and 10 show the descriptive statistics for the demographic characteristics of each sample 
population across the four branches of service.  The sample population trends across all 
branches of service show single, white, and male represent the largest demographic 
groups.  The Marines gender difference is the greatest across all branches of service with 
only 4.0 percent of females represented in both the major depression and substance abuse 
sample populations.  The mean age is 27 for both major depression and substance abuse 





Table 9.   Descriptive Statistics of Demographic Characteristics for Major Depression 
Samples of the Four Branches of Service 
Major Depression Demographic 
Characteristics Army Marines Navy 
Air 
Force 
Sample Size 334,871 98,808 134,734 112,956 
Gender         
Male 88.2% 96.0% 86.4% 83.0% 
Female 11.8% 4.0% 13.6% 17.0% 
Marital Status         
Single 53.2% 69.2% 55.0% 48.3% 
Married 46.8% 30.8% 45.0% 51.7% 
Race         
White 63.8% 71.3% 57.3% 74.0% 
Black 19.6% 10.2% 21.5% 15.4% 
Hispanic 6.8% 8.1% 7.2% 3.4% 
Asian 3.8% 2.8% 5.9% 2.2% 
Other races 6.0% 7.6% 8.0% 5.0% 
Age 28 23 27 28 
 
Table 10.   Descriptive Statistics of Demographic Characteristics for Substance Abuse 
Samples of the Four Branches of Service 
Substance Abuse Demographic 
Characteristics Army Marines Navy 
Air 
Force 
Sample Size 334,434 98,778 134,711 112,846 
Gender         
Male 88.2% 96.0% 86.3% 83.0% 
Female 11.8% 4.0% 13.7% 17.0% 
Marital Status         
Single 53.3% 69.1% 55.2% 48.4% 
Married 46.7% 30.9% 44.8% 51.6% 
Race         
White 63.8% 71.2% 57.3% 74.1% 
Black 19.6% 10.2% 21.5% 15.4% 
Hispanic 6.8% 8.1% 7.3% 3.4% 
Asian 3.8% 2.8% 5.9% 2.2% 
Other races 5.9% 7.6% 8.0% 5.0% 
Age 28 23 27 28 
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D. RATE OF MAJOR DEPRESSION AND SUBSTANCE ABUSE 
DIAGNOSIS 
1. Overall Rate of Diagnosis for Major Depression and Substance Abuse 
Figures 1 and 2 show the overall rates of diagnosis for major depression and 
substance abuse across the four branches of service.  The differences in rate of diagnosis 
for major depression and substance abuse are noticeable in the sample populations.  The 
overall rate of major depression diagnosis is highest for the Air Force, 3.0 percent 
whereas the highest overall rate of substance abuse is largest for the Navy at 8.8 percent.  
Substance abuse rates are significantly higher than rates of diagnosis for major depression 
for the sample populations.  The average rate of diagnosis across the four services for 
substance abuse is 7.2 percent as compared to major depression diagnosis with an 
average rate of 2.3 percent.  The higher rate of substance abuse diagnosis may be due to 
aggressive screening and awareness of substance abuse issues in the military.  
 
 





Figure 2.   Overall Rate of Diagnosis of Substance Abuse 
a. Rate of Deployment Characteristics for Major Depression  
The overall rates of major depression and the major depression rate by 
deployment history are shown in Table 11.  
 
Table 11.   Rate of Major Depression Diagnosis by Deployment Duration and Location 
Rate of Major Depression Diagnosis Army Marines Navy Air Force
      
Sample Size with Major Depression 8,366 1,703 3,222 3,667 
Based on Deployment History     
Non-Deployed Population 1.5% 1.1% 2.0% 2.9% 
Ever Deployed under OEF/OIF 5.1% 3.4% 2.7% 3.4% 
Ever Deployed to Afghanistan or Iraq 3.0% 2.4% 2.5% 2.5% 
Ever Deployed to Classified or Unknown 
Location 1.9% 1.1% 1.7% 2.1% 
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The rate of major depression diagnosis is similar across the four services. 
Generally, the percentage of non-deployed personnel diagnosed with major depression is 
less than 3 percent  The rate of diagnosis for personnel who were ever deployed under 
OEF and OIF (regardless of locations) for the sample population is highest for Army 
enlisted personnel at a 5.1 percent for the study period, and lowest among the Navy 
personnel at a 2.7 percent.  For people who were ever deployed to Afghanistan or Iraq, 
the rate of major depression diagnosis is highest for the Army at 3.0 percent diagnosed.  
Across the four services, the rate of diagnosis for major depression when those who were 
deployed to a classified or unknown location is smallest out of all categories evaluated.  
Marines show the smallest rate of diagnosis at 1.1 percent of the sample population.  
b. Rate of Deployment Duration (Total Days Deployed) for Major 
Depression 
Analysis of the total days deployed under OEF and OIF shows (Figure 3) 
that rates of diagnosis with major depression increase considerably after 120 days of 
deployment.  This is not to say, that rates of diagnosis for non-deployed or deployment of 
1 to 120 days are trivial.  Simply, that in the sample population, the rates of diagnosis 
tend to increase with total days of deployment.  The Air Force, for example, tends to 
show the greatest increase, 26.6 percent in major depression diagnosis for those who have 
deployments of 121 to 180 days as compared to total days of deployment greater than one 
year—24.0 percent.  The same trend is noted with the other three branches of service.  
The highest rate of diagnosis in the Army sample population is 11.1 percent for total days 
of deployment, 121 to 180 days.  The Marines show a 6.5 percent rate of major 
depression diagnosis for both total days deployed of 121 to 180 days and greater than one 
year 7.2 percent.  The Navy sample population experiences the highest rate of diagnosis 
at 121 to 180 days of deployment.  Overall, the greatest effect on the increase in rates of 
major depression diagnosis across the four branches of service comes from total days of 




Figure 3.   Rate of Major Depression Diagnosis by Duration of Total Days Deployed 
c. Rate of Deployment Characteristics for Substance Abuse 
Table 12 shows the rates of substance abuse diagnosis for deployment 
location and duration (total days deployed). The table represents the total sample 
population across the four service branches that have a diagnosis of substance abuse. 
Table 12.   Rate of Substance Abuse Diagnosis by Deployment Duration and Location 
Rate of Substance Abuse 
Diagnosis 
Army Marines Navy Air Force 
Sample Size with Substance Abuse 25,804 5,931 11,898 6,871 
Based on Deployment History     
Non-Deployed Population 5.7% 4.8% 7.8% 5.8% 
Ever Deployed under OEF/OIF 13.4% 8.9% 10.4% 6.3% 
Ever Deployed to Afghanistan or Iraq 14.8% 9.4% 8.7% 7.1% 
Ever Deployed to Classified or 
Unknown Location 5.7% 9.1% 10.4% 4.6% 
Days Deployed 0 (not deployed) 5.7% 4.8% 7.8% 5.8% 
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Table 12 shows the rate of substance abuse diagnosis is slightly different 
from the major depression rates. Generally, the percentage of the non-deployed personnel 
diagnosed with substance abuse is less than 8 percent. For enlisted personnel who were 
ever deployed under any OEF and OIF (regardless of locations), the Army and Navy 
show the highest rates of substance abuse. Army enlisted personnel who were ever 
deployed to Afghanistan or Iraq for the study period show the highest rate of diagnosis 
out of the four branches. Similar to the major depression rates, substance abuse rates of 
diagnosis for those people who were ever deployed to a classified or unknown location is 
generally smaller than the deployment to other locations. Navy personnel who were ever 
deployed under OEF and OIF (regardless of locations) and those who were ever deployed 
to a classified or unknown location have the largest rates at 10.4 percent, which is only 
1.7 percentage points greater than those who were ever deployed to Afghanistan or Iraq 
at 8.7 percent. Dissimilar to the other three services, Navy rates of diagnosis appear 
equally great for any OEF or OIF, and a classified or unknown location.  
d. Rate of Deployment Duration (Total Days Deployed) for 
Substance Abuse  
Figure 4 shows the rate of substance abuse diagnosis for the duration of 
deployment (total days deployed) for all four branches of service.  Similar to the major 
depression trend, the percentage of substance abuse diagnosis is greatest for the sample 
population that has deployed greater than 121 to 180 days in total.  There is a consistent 
trend for increases in rate of diagnosis for the Army, Navy, and Air Force with increased 
number of days deployed.  The Navy, on the other hand, experiences the highest rate of 




Figure 4.   Rate Substance Abuse Diagnosis Duration of Total Days Deployed 
E. RESULTS OF REGRESSION ANALYSIS: EFFECT OF DEPLOYMENT 
ON PROBABILITY OF BEING DIAGNOSED WITH MAJOR 
DEPRESSION OR SUBSTANCE ABUSE 
This section discusses the results of the multivariate probit models used to 
estimate the effects of deployment on the probability of being diagnosed with major 
depression or substance abuse.  Independent analyses were conducted for each model 
across the four branches of service for the enlisted population between 2001 and 2006. 
The results were then compared across the services to evaluate whether differences exist 
in the sample populations.  
Four multivariate probit models were used in this thesis, with each model 
analyzed separately for the Army, Marines Corps, Navy, and Air Force enlisted study 
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population. The key variables of interest used to estimate deployment effects on the 
probability of being diagnosed with major depression or substance abuse naturally 
change with each model (i.e., the ever being deployed variables, frequency of deployment 
variables and  total days of deployment variables).  Service characteristics, such as MOS 
and rank, and demographic variables, such as marital status, gender, race, age, and year 
dummies, remain constant for all four models.  One probit model contains frequency 
variables as the key variables and uses total days deployed as the continuous variable.  
This model is used with the third multivariate model to show the effect of the frequency 
of tours. A brief description of the three main models used for analysis is provided below.  
1. Model Descriptions 
a. Model 1: Effect of Ever Being Deployed by Location 
The first model estimates the effect of ever being deployed to a location 
on the probability of being diagnosed with major depression or substance abuse.  Ever 
deployed refers to an individual who has at any time been deployed under OEF and OIF 
prior to a diagnosis of major depression or substance abuse.  Model 1 also examines 
whether a sailor has ever been deployed to ship or shore. 
b. Model 2: Effect of Total Days Deployed and Ever Being 
Deployed 
The second model considers the effect of total days of deployment, while 
controlling for deployment location on the probability of being diagnosed with major 
depression or substance abuse.  The total days of deployment is divided into categories 




c. Model 3 and 3.a: Effect of Frequency of Deployment Under 
OEF/OIF 
The third model estimates the effect of frequency of deployment under 
OEF and OIF on the probability of being diagnosed with major depression or substance 
abuse.  The model uses variables to estimate the effect of the number of deployments 
under OEF and OIF and to Afghanistan or Iraq during the study period.  
2. Results of Model 1: Effect of Ever Being Deployed By Location for 
Major Depression and Substance Abuse 
a. Model 1 Results for Major Depression  
The first multivariate probit model estimates the effects of those who were 
ever deployed on the probability of being diagnosed with major depression and substance 
abuse.  In addition to this model, the effect on Navy sailors who were deployed to shore 
is analyzed. Table 13 shows the results of the probit model for major depression across 
the four branches of service and Table 14 shows the results for the substance abuse 













Table 13.   Model 1: Effects of Ever Being Deployed on Major Depression 
 Model 1 
Effect of Ever Being Deployed on 
Major Depression 
Army Marines Air Force Navy 
Location of Deployment 
(reference group is not 
deployed under OEF/OIF) 
        
Ever Deployed 0.037*** 0.018*** 0.014*** 0.023*** 
  (0.001) (0.001) (0.001) (0.002) 
Ever Deployed to Afghanistan or 
Iraq 0.002** 0.006*** 0.001 0.011*** 
  (0.001) (0.001) (0.002) (0.004) 
Ever Deployed to  Classified 
Location -0.011*** -0.004*** -0.007*** -0.005*** 
  (0.001) (0.001) (0.001) (0.001) 
Ever Deployed to Shore       -0.013*** 
        (0.001) 
Sample size 334,871 98,808 112,956 
        
134,734  
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
All deployment variables are statistically significant at the conventional 
level, except for Air Force when comparing deployment to Afghanistan and Iraq to 
deployment to other locations.  The reference group is comprised of those who were 
never deployed.  
The effect of those who were ever deployed for the average enlisted 
person in the Army is a 0.037 or 3.7 percentage points change in the probability of being 
diagnosed with major depression. Among those who deployed, being deployed to 
Afghanistan or Iraq results in an even higher rate of major depression compared to those 
who deployed to other known locations. Specifically, this location category raises the 
probability of major depression by 0.2 percentage points on top of the 3.7 percentage 
point increase. The final coefficient ever deployed to a classified or unknown location is 
negative (-0.011, p<0.01), indicating that the effect of those soldiers who deployed to a 
classified or unknown location is a 2.6 percentage points change (3.7-1.1=2.6).  
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The Marines Corps results show the effect of those who were ever 
deployed for the average Marines is a 0.018 or 1.8 percentage points change in the 
probability of being diagnosed with major depression. Deployment to Afghanistan or Iraq 
further increases that probability by another 0.6 percentage points change. Deployment to 
a classified or unknown location has a moderating effect, reducing the rate of major 
depression by a -0.4 percentage points compared to those who deployed to other known 
locations (i.e., the average rate of major depression among those Marine Corp personnel 
is 1.8-0.4=1.4 percent). 
For the Air Force, the effect of those who were ever deployed for the 
average enlisted is a 0.014 or 1.4 percentage points change in the probability of being 
diagnosed with major depression. Deployment to Afghanistan or Iraq only slightly 
increases the probability by a 0.01 percentage point, thus making the probability a 1.5 
percentage points change. Like the Army and Marines, the probability of those airmen 
who were deployed, regardless of location is significant. However, Air Force personnel 
exhibit the smallest increases, which is perhaps related to the difference in front line 
combat exposure between the services. The coefficient ever deployed to a classified or 
unknown location shows airmen have a much lower probability of being diagnosed with 
major depression as compared to the other categories with a 0.7 percentage points effect 
in the probability in diagnosis with major depression. 
Results show for the Navy, being deployed to Afghanistan or Iraq is the 
largest probability of diagnosis with major depression for all deployment location 
categories at a 3.5 percentage points change, this is a 1.1 percentage point increase over 
personnel who were ever deployed under OEF and OIF. The effect of those who were 
ever deployed to any OEF and OIF location for the average sailor is a 0.024 or 2.4 
percentage points change in the probability of being diagnosed with major depression. 
The coefficient ever deployed to a classified or unknown location and deployed to shore, 
has a moderating effect. Deployed to a classified or unknown location shows the average 
sailor has a negative coefficient, -0.005, the adjusted percentage points difference is a 1.9 
percentage points change in the probability of being diagnosed with major depression;  
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deployed to shore is a 1.1 percentage points change. This indicates sailors have a smaller 
risk of major depression when deployed to shore or a classified location as compared to 
deployments to other OEF and OIF locations. 
b. Summary of Model 1 Major Depression Across the Four 
Branches of Service 
Table 13 shows that the average active duty enlisted person for the Army, 
Marine Corps, Air Force, and Navy has a higher probability of being diagnosed with 
major depression if they were ever deployed under OEF and OIF between 2001 and 2006 
than those who were never deployed. Deployment to Afghanistan and Iraq increases the 
probability of major depression even more compared to those who deployed to other 
known locations for all services, except for the Air Force. On the other hand, deployment 
to a classified or unknown location or shore for Navy, appear to moderate the rate of 
major depression diagnosis compared to deployment to other locations, although this 
group of enlisted still has a higher rate of diagnosis as compared to the non-deployed 
population.  
c. Model 1 Results for Substance Abuse  
The first multivariate probit model estimates the effects of ever being 
deployed on the probability of being diagnosed with substance abuse.  In addition to this 
model, the effects of Navy sailors deployed to shore are analyzed. Table 14 shows the 









Table 14.   Model 1: Effects of Ever Being Deployed on Substance Abuse 
 Model 1 
Effect of Ever Being Deployed 
on Substance Abuse 
Army Marines Air Force Navy 
Location of Deployment 
(reference group is not 
deployed under OEF/OIF) 
        
Ever Deployed 0.116*** 0.061*** 0.030*** 0.074*** 
  (0.002) (0.003) (0.002) (0.005) 
Ever Deployed to Afghanistan or 
Iraq 0.016*** 0.023*** 0.008** -0.008 
  (0.002) (0.004) (0.003) (0.007) 
Ever Deployed to Classified 
Location -0.043*** 0.004 -0.017*** -0.002 
  (0.001) (0.003) (0.002) (0.003) 
Ever Deployed to Shore       -0.021*** 
        (0.003) 
Sample size 334,434 98,778 112,846 134,711 
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
All deployment variables are statistically significant at the conventional 
level, except for Navy when comparing deployment to Afghanistan and Iraq to 
deployment to other locations and for deployments to a classified or unknown location 
for Marines and Navy. The reference group is comprised of those who were never 
deployed.  
The effect of those who were ever deployed for the average enlisted 
person in the Army is a 0.116 or 11.6 percentage points change in the probability of being 
diagnosed with substance abuse.  The probability increases among those who were 
deployed to Afghanistan or Iraq by an additional 1.6 percentage points. This represents 
the highest probability of diagnosis, totaling 13.2 percentage points, indicating that 
deployment, specifically to Afghanistan or Iraq poses a significant risk to Army 
personnel. The final coefficient ever deployed to a classified or unknown location is a  




a classified or unknown location have a 7.3 percentage points higher probability of being 
diagnosed with substance abuse compared to the non-deployed population (11.6-4.3=7.3 
percentage points).  
For Marines the effect of those who were ever deployed for the average 
enlisted person is a 6.1 percentage points change in the probability of being diagnosed 
with substance abuse. Deployments to Afghanistan or Iraq increases the probability of 
diagnosis by a added 2.3 percentage points change, the adjusted difference increases the 
probability to an 8.4 percentage points change, showing that deployments to Afghanistan 
or Iraq have a much higher effect for Marines.  
The Air Force results show that airmen who were ever deployed is a 3.0 
percentage point change in the probability of being diagnosed with substance abuse. For 
the Air Force deployments solely to Afghanistan or Iraq is the highest probability of 
diagnosis with substance abuse, 3.8 percentage points (3.0+0.8=3.8). Deployments to 
Afghanistan or Iraq, specifically places airmen at the greatest risk for a diagnosis of 
substance abuse.  However, the rate of diagnosis is smaller than the other services, which 
may be due to less frontline combat exposure. Similar to the other services deployment to 
a classified or unknown location shows a moderating effect, reducing the rate of 
substance abuse for the average person in the Air Force. The effect has a negative 
coefficient, (-1.7, p.<0.01), with the adjusted difference of a 1.3 percentage points change 
in the probability of being diagnosed with substance abuse for deployment to a classified 
or unknown location, indicating this deployment category has a smaller risk of diagnosis 
for airmen.  
For the Navy results show two statistically significant coefficients, ever 
deployed and ever deployed to shore. The effect for the average sailor who was ever 
deployed is a 0.074 or 7.4 percentage points change in the probability of being diagnosed 
with substance abuse. Among those who deployed to shore the results are lower rates of 
substance abuse as compared to those who were deployed to sea under OEF and OIF.  
Specifically the probability of being diagnosed with substance abuse for those who were 
deployed to shore is a negative, -2.1, indicating the effect of shore deployment is a 5.3 
percentage points change. For the Navy, the magnitude is smallest for those sailors who 
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were deployed to shore, and is consistent with the major depression shore deployments 
finding, indicating no significant difference exists in the probability of diagnosis for 
shore deployments.   
d. Summary of Model 1 Substance Abuse Across the Four 
Branches of Service 
Table 14 shows that the average active duty enlisted person for the Army, 
Marine Corps, Air Force, and Navy has a higher probability of being diagnosed with 
substance abuse if they were ever deployed under OEF and OIF between 2001 and 2006 
than those who never deployed.  The magnitude of the effect is even bigger than those 
reported in Table 13 (major depression).  The effect of location is similar to the results 
from Table 13, in that deployment to Afghanistan and Iraq increases the probability of 
substance abuse even more compared to those who deployed to other known locations for 
all services, except for Air Force. On the other hand, deployment to a classified or 
unknown location or shore for Navy, appear to moderate the rate of substance abuse 
diagnosis compared to deployment to other locations, although this group of enlisted still 
has a higher rate of diagnosis as compared to the non-deployed population.  
3. Results of Model 2: Effect of Total Days Deployed 
The second model considers the total days of deployment and evaluation between 
ever being deployed to a specific location on the probability of being diagnosed with 
major depression or substance abuse. The total days of deployment is isolated into groups 
to estimate whether the number of days deployed affects the probability of being 
diagnosed with either of the dependent variables. Table 15 shows the results of the probit 
model for major depression for all branches of service and Table 16 shows the results for 






Table 15.   Model 2: Effects of Total Days of Deployment on Major Depression 
 Model 2 
Effects of Total Days of Deployment on 
Major Depression 
Army Marines Air Force Navy 
Deployment Days (reference group 
not deployed) 
        
Days Deployed 1 to 120 0.040*** 0.018*** 0.016*** 0.013*** 
  (0.001) (0.001) (0.001) (0.002) 
Days Deployed 121 to 180 0.079*** 0.013* 0.103*** 0.077*** 
  (0.011) (0.007) (0.017) (0.016) 
Days Deployed 181 to 365 0.053*** 0.006* 0.034*** 0.077*** 
  (0.004) (0.003) (0.011) (0.011) 
Days Deployed 366 Plus 0.048*** 0.017*** 0.077*** 0.074*** 
  (0.004) (0.006) (0.025) (0.021) 
Ever Deployed to Afghanistan or Iraq 0.001* 0.006*** 0.001 0.011*** 
  (0.001) (0.001) (0.002) (0.004) 
Ever Deployed to  Classified Location -0.011*** -0.004*** -0.007*** -0.007*** 
  (0.001) (0.001) (0.001) (0.001) 
Sample size 334,871 98,808 112,956 134,734 
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
a. Model 2 Results for Major Depression  
All deployment variables are statistically significant at the conventional 
level, except for Air Force when comparing deployment to Afghanistan and Iraq to the 
total days deployment variables. The reference group is zero days deployed, or otherwise 
stated never deployed.  
The effect of those who were deployed from 1 to 120 days for the average 
active duty enlisted Army service member is a 0.04 or 4.0 percentage point change in the 
probability of being diagnosed with major depression. For those who deployed from 121 
to 180 days the probability is a 7.9 percentage points change. Deployment for four to six 
months shows the highest probability of diagnosis with major depression for soldiers.  
Deployments of 181 to 365 days the coefficient is 0.053 meaning that the percentage 
points change is 5.3. This indicates that, for the Army, six months to a year of 
deployment has the second highest probability of diagnosis. Finally, the effect of those 
who deployed greater than 365 days is a 0.048 or 4.8 percentage points change in the 
probability of being diagnosed with major depression. 
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The analysis shows that for the Marines, the largest effect of those who 
were deployed from 1 to 120 days is a 1.8 percentage points change in the probability of 
being diagnosed with major depression whereas, the smallest probability of being 
diagnosed with major depression is when deployment is 181 to 365 days, a 0.6 
percentage points change.  A possible theory is a selection bias issue exists in the first 
few months of the deployment for enlisted Marines. 
The Air Force’s largest effect is similar to the Army results. Those airmen 
who were deployed for 121 to 180 days show a 0.103 or 10.3 percentage points change in 
the probability of being diagnosed with major depression. The smallest effect for airmen 
is deployment from 1 to 120 days, which is a 1.6 percentage points change in the 
probability of being diagnosed with major depression. The Air Force’s probability of 
major depression is generally highest out of all the services.  It is unclear, but this may be 
a reflection of deployment tempos specific to the Air Force.  
For the Navy the largest effect of being deployed, is similar to the Army 
and the Air Force. For those sailors who were deployed for 121 to 180 days the results 
show a 7.7 percentage points change in the probability of being diagnosed with major 
depression. However, for those who deployed for 181 to 365 days the result is equally as 
high, 7.7 percentage points change. Deployment greater than 365 days is slightly lower at 
a 7.4 percentage points change in the probability of diagnosis. The smallest coefficient is 
deployment for 1 to 120 days, with a 0.013 or 1.3 percentage points change in the 
probability of being diagnosed with major depression. The larger effects for the Navy, 
deployed essentially for 121 to 365 days may be attributed to the deployment tempos 
Navy personnel experience. Longer deployments appear to increase the probability of 
diagnosis with major depression.  
b. Summary of Model 2 Major Depression Across the Four 
Branches of Service  
Model 2 shows that multiple days of deployment increases the probability 
of being diagnosed with major depression for the average active duty enlisted person 
across the four branches of service. Total days deployed of 121 to 180 for the Army, Air 
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Force and Navy are the highest probability of being diagnosed. However, for the Marine 
Corps deployed for 1 to 120 days and greater represents the highest probability of 
diagnosis. It appears that deployments ranging from six months to a year have a more 
pronounced effect on service personnel. The slight variability in the findings may be a 
reflection of duration of deployments for each service. Interestingly, the Air Force shows 
the largest increase in probability of diagnosis with major depression with a 10.3 
percentage points change. The large magnitude for the Air Force is unclear, but the 
significantly larger probability could be attributed to a selection bias or to deployment 
tempos, which differ across the services. Furthermore, the more days deployed in general 
increases the probability of diagnosis of major depression regardless of branch of service.  
c. Model 2 Results for Substance Abuse  
Table 16 shows the results of the probit model for substance abuse across 
the four branches of service. 
Table 16.   Model 2: Effects of Total Days of Deployment on Substance Abuse 
 Model 2 
Effects of Total Days of Deployment 
on Substance Abuse 
Army Marines Air Force Navy 
Deployment Days (reference group 
is not deployed) 
        
Days Deployed 1 to 120 0.119*** 0.064*** 0.031*** 0.058*** 
  (0.002) (0.003) (0.002) (0.004) 
Days Deployed 121 to 180 0.070*** 0.080*** 0.050*** 0.077*** 
  (0.013) (0.022) (0.018) (0.023) 
Days Deployed 181 to 365 0.094*** 0.074*** 0.039** 0.093*** 
  (0.006) (0.012) (0.017) (0.015) 
Days Deployed 366 plus 0.100*** 0.080*** 0.053** 0.116*** 
  (0.007) (0.016) (0.027) (0.029) 
Ever Deployed to Afghanistan or Iraq 0.016*** 0.022*** 0.008** -0.007 
  (0.002) (0.003) (0.003) (0.007) 
Ever Deployed to  Classified 
Location -0.042*** 0.003 -0.017*** -0.004 
  (0.001) (0.003) (0.002) (0.003) 
Sample size 334,434 98,778 112,846 134,711 
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
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All deployment variables are statistically significant at the conventional 
level, except for Navy when comparing deployment to Afghanistan and Iraq to the 
frequency of deployment variables and for deployments to a classified locations for 
Marines and Navy. The reference group is those who were never deployed.  
Analysis results for the Army show that the largest effects are for those 
who deployed from 1 to 120 days and those who deployed greater than 365 days.  
Soldiers who deployed from 1 to 120 days have a 11.9 percentage points change in the 
probability of being diagnosed with substance abuse. This indicates soldiers who were 
deployed from 1 to 120 days have the highest risk of being diagnosed with substance 
abuse out of all the categories. Those who deployed greater than 365 days show a 10.0 
percentage points effect in the probability of being diagnosed with substance abuse. 
Being deployed greater than a year indicates the second highest risk for being diagnosed 
with substance abuse. For soldiers who deployed from 121 to 180 days, the probability is 
a 7.0 percentage points change in probability of being diagnosed and is the smallest effect 
on diagnosis for soldiers. For deployments from 181 to 365 days, the coefficient is 0.094 
meaning that the percentage points change is 9.3. 
The Marines show the effect of those who were deployed from 121 to 180 
days and those who were deployed more than 365 days for the average active duty 
enlisted person is a 0.080 or 8.0 percentage points change in the probability of being 
diagnosed with substance abuse. This represents the largest probability of substance 
abuse diagnosis for the Marine Corps sample population. This result is a striking 
difference from the major depression findings, suggesting that there may be more than a 
selection bias issue. In general the results for the Marines indicate that more days 
deployed increases the probability of diagnosis with substance abuse. 
Air Force results show the effect of those airmen who were deployed more 
than 365 days is a 5.3 percentage points change in the probability of being diagnosed 
with substance abuse. The second largest coefficient is deployed from 121 to 180 days at 
a 0.050 or 5.0 percentage points change in probability of diagnosis with substance abuse. 
The Air Force findings are slightly different from the Army and Marines, which may be 
attributed to deployment tempo’s specific to each branch. 
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Navy results indicate the effect of those who were deployed more than 365 
days for the average sailor is an 11.6 percentage points change in the probability of being 
diagnosed with substance abuse. This represents the largest probability of diagnosis for 
the Navy, and mirrors the findings from the Marines and Air Force. The Navy 
deployment days show a clear trend in the probability of substance abuse diagnosis. The 
greater the number of days deployed, the higher the probability of substance abuse 
diagnosis, indicating the linear relationship is strong. This may be a result of Navy 
personnel turning to alcohol or other substances to cope with deployment.  
d. Summary of Model 2 Substance Abuse Across the Four 
Branches of Service 
Table 16 shows that in general multiple days of deployment increase the 
probability of being diagnosed with substance abuse for the average active duty enlisted 
person across the four branches of service. However, the results differ considerably from 
the major depression model, in that deployed greater than 365 days for the Marine Corps, 
Air Force and Navy has the highest probability of being diagnosed, whereas for major 
depression, generally, 121 to 180 days had the highest probability. The Army experiences 
the highest probability at an 11.9 percentage point change for those who deployed for 1 to 
120 days, but for those who deployed greater than 365 days the probability is a 10.0 
percentage point increase. This indicates that for the Army the highest probability is 1 to 
120 days deployed, but like the other branches of service deployed greater than 365 days 
is relatively high. The more days deployed in general increases the probability of being 
diagnosed with substance abuse across the service branches. For the Navy in particular 
there is a strong linear relation.  
4. Results of Model 3: Effect of Frequency of Deployments under OEF 
and OIF 
The third model estimates the effect of frequency of deployment under OEF and 
OIF on the probability of being diagnosed with major depression or substance abuse. The 
model uses variables to estimate the effect of frequency of deployment under OEF and 
OIF and to Afghanistan or Iraq during the study period 2001–2006. Table 17 shows the 
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results of the probit model for major depression across the four branches of service and 
Table 18 shows the same model but using total days as a continuous variable. Tables 19 
and 20 show the results for the substance abuse sample population. 
 
Table 17.   Model 3: Effects of Frequency of Deployments and Location on Major 
Depression 
 Model 3 
Effects of Frequency of 
Deployments and Location on 
Major Depression  
Army Marines Air Force Navy 
Duration of Deployment  
(reference group is not 
deployed)         
Deployed Only Once 0.064*** 0.034*** 0.026*** 0.010*** 
  (0.002) (0.003) (0.002) (0.001) 
Deployed Twice 0.019*** 0.003 0.001 -0.004*** 
  (0.003) (0.002) (0.002) (0.001) 
Deployed Three or More Times 0.014*** 0.003 -0.006*** -0.008*** 
  (0.002) (0.002) (0.002) (0.002) 
Deployed to Afghanistan or Iraq 
Only Once 0.001 0.006*** 0.004 0.028*** 
  (0.001) (0.002) (0.003) (0.006) 
Deployed to Afghanistan or Iraq 
Twice 0.025*** 0.004 -0.002 0.014 
  (0.003) (0.003) (0.004) (0.009) 
Deployed to Afghanistan or Iraq 
Three or More Times 0.001 0.012*** -0.002 -0.010 
  (0.001) (0.004) (0.006) (0.008) 
Sample size 334,871 98,808 112,956 134,734  
Standard errors in parentheses     










Table 18.   Model 3a: Effects of Frequency of Deployments and Location on Major 
Depression Controlling for Total Days 
 Model 3.a 
Effects of Frequency of 
Deployments and Location on 
Major Depression Controlling for 
Total Days  
Army Marines Air Force Navy 
Duration of Deployment  
(reference group is not 
deployed)         
Deployed Only Once 0.067*** 0.035*** 0.026*** 0.011*** 
  (0.002) (0.003) (0.002) (0.001) 
Deployed Twice 0.021*** 0.003* 0.002 -0.004*** 
  (0.003) (0.002) (0.002) (0.001) 
Deployed Three or More Times 0.015*** 0.003 -0.005*** -0.008*** 
  (0.002) (0.002) (0.002) (0.002) 
Deployed to Afghanistan or Iraq 
Only Once 0.001 0.006*** 0.003 0.027*** 
  (0.001) (0.002) (0.003) (0.006) 
Deployed to Afghanistan or Iraq 
Twice 0.024*** 0.004 -0.002 0.014 
  (0.003) (0.003) (0.004) (0.009) 
Deployed to Afghanistan or Iraq 
Three or More Times 0.000 0.012*** -0.002 -0.010 
  (0.001) (0.004) (0.006) (0.008) 
Total Days Deployed 0.000*** 0.000*** 0.000*** 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
          
Sample size 334,871 98,808 112,954 134,724 
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
a. Model 3 Results for Major Depression  
The coefficients deployed only once and deployed three or more times 
under OEF and OIF are statistically significant at the conventional level for all branches 
of service. Deployed twice under any OEF and OIF is only significant for the Army and 
Navy, while deployed to Afghanistan or Iraq only once is statistically significant for the 
Marine Corps and Navy. The coefficient deployed to Afghanistan or Iraq only twice is  
 
 66
only significant for the Army at the conventional level and deployed to Afghanistan or 
Iraq three or more times is significant only for the Marine Corps. The reference group is 
comprised of those who have never deployed.  
Looking at the results for the Army the effect of those who were deployed 
only once for the average enlisted soldier is 0.064 or a 6.4 percentage points change in 
the probability of being diagnosed with major depression.  This is the highest probability 
of diagnosis for the Army and suggests that first deployments affect future readiness. The 
effect of those who had two deployments under OEF and OIF on the average soldier is a 
1.9 percentage point change in the probability of being diagnosed with major depression 
and those who were deployed three or more times is a 1.5 percentage point change in the 
probability of being diagnosed with major depression. For soldiers who deployed to 
Afghanistan or Iraq twice, the effect further exacerbates the probability of being 
diagnosed with major depression by an additional 2.5 percentage points. This indicates 
soldiers have an even higher risk when deployed to Afghanistan or Iraq compared to 
those who deployed to other OEF or OIF locations.   
The Marine Corps analysis shows the effect of the average enlisted person 
who was deployed only once has a 0.034 or 3.4 percentage points change in the 
probability of being diagnosed with major depression.  Among those who were deployed 
once to Afghanistan or Iraq the probability is even higher, a 4.0 percentage points change 
(i.e., the adjusted difference is 3.4+0.6=4.0). Similar to the Army, those Marines who 
ever deployed, regardless of location have the greatest likelihood of diagnosis with major 
depression. For Marines who had three or more deployments to Afghanistan or Iraq the 
effect is a 1.5 percentage points change and in the probability of being diagnosed with 
major depression, indicating that more deployments have a smaller effect than the initial 
deployment. 
For the Air Force, those who were deployed only once for the average 
enlisted person is a 0.026 or a 2.6 percentage points change in the probability of being 
diagnosed with major depression. The finding is similar to the Army and Marine Corps—
deployed only once has the highest probability of diagnosis. Those airmen who had three 
or more deployments under OEF and OIF show a lower probability of being diagnosed 
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with major depression (-.06 percentage point, p<0.01). The results indicate that the first 
deployment has the most significant influence on the probability of diagnosis. This may 
be evidence of a selection bias, meaning that those individuals who are found unfit for 
additional deployments are not sent on in future deployments.  
Analysis of the results for the Navy show the effect of the average sailor 
who deployed only once is a 1.0 percentage points change in the probability of being 
diagnosed with major depression. Two deployments and those who had three or more 
deployments under OEF and OIF have a lower the probability of being diagnosed with 
major depression by a - 0.4 and a - 0.08 percentage points, respectively. This indicates 
that when compared to one deployment the probability of being diagnosed with major 
depression is nearly insignificant. For sailors who deployed to Afghanistan or Iraq only 
once, the probability of being diagnosed with major depression increases by 2.8 
percentage points. This further supports that the initial deployment pose the greatest risk 
of diagnosis for major depression. 
b. Summary of Model 3 Major Depression Across the Four 
Branches of Service 
Table 17 shows that multiple deployments increase the probability of 
being diagnosed with major depression for the average active duty enlisted person for the 
Army, Marine Corps, Air Force, and Navy. For the Air Force and Navy, the rate of 
diagnosis with major depression appears to be moderated for three or more deployments.  
More importantly, analysis of deployment frequencies highlights the selection bias when 
using deployment history. The results indicate that personnel deployed only once under 
OEF and OIF (regardless of location) have the highest probability of being diagnosed 
across all four branches of service. This may again be due to a selection bias—those 
diagnosed after the first deployment were found unfit for future deployments, thus 
excluding them from subsequent deployment. Model 3.a demonstrates results are similar 
whether total days deployed were included as the control variable.  
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c. Model 3 Results for Substance Abuse  
Table 19 shows the results of the probit model for substance abuse across 
the four branches of service. Table 20 shows the same model, but using total days as a 
continuous variable.  
 
Table 19.   Model 3: Effects of Frequency of Deployments and Location on Substance 
Abuse 
 Model 3 
 Effects of Frequency of 
Deployments and Location on 
Substance Abuse 
Army Marines Air 
Force 
Navy 
Duration of Deployment  
(reference group is not deployed)         
Deployed Only Once 0.169*** 0.102*** 0.041*** 0.072*** 
  (0.004) (0.005) (0.003) (0.003) 
Deployed Twice 0.042*** 0.042*** 0.020*** 0.036*** 
  (0.005) (0.005) (0.003) (0.003) 
Deployed Three or More Times 0.080*** 0.042*** 0.001 0.018*** 
  (0.003) (0.006) (0.003) (0.005) 
Deployed to Afghanistan or Iraq 
Only Once 0.012*** 0.033*** 0.017*** 0.001 
  (0.003) (0.005) (0.005) (0.010) 
Deployed to Afghanistan or Iraq 
Twice 0.112*** 0.005 0.004 -0.001 
  (0.008) (0.006) (0.006) (0.013) 
Deployed to Afghanistan or Iraq 
Three or More Times 0.024*** 0.014** 0.008 -0.038** 
  (0.003) (0.007) (0.010) (0.019) 
Sample size 334,434 98,778 112,846 134,711 
Standard errors in parentheses     









Table 20.   Model 3a: Effects of Frequency of Deployments and Location on Substance 
Abuse Controlling for Total Days 
 Model 3.a 
Effects of Frequency of 
Deployments and Location on 
Substance Abuse Controlling for 
Total Days  
Army Marines Air Force Navy 
Duration of Deployment  
(reference group is not deployed)         
Deployed Only Once 0.173*** 0.103*** 0.041*** 0.073*** 
  (0.004) (0.005) (0.003) (0.003) 
Deployed Twice 0.045*** 0.043*** 0.020*** 0.036*** 
  (0.005) (0.005) (0.003) (0.003) 
Deployed Three or More Times 0.082*** 0.043*** 0.001 0.019*** 
  (0.003) (0.006) (0.003) (0.005) 
Deployed to Afghanistan or Iraq 
Only Once 0.011*** 0.033*** 0.017*** 0.001 
  (0.003) (0.005) (0.005) (0.010) 
Deployed to Afghanistan or Iraq 
Twice 0.110*** 0.005 0.004 -0.001 
  (0.008) (0.006) (0.006) (0.013) 
Deployed to Afghanistan or Iraq 
Three or More Times 0.023*** 0.013** 0.008 -0.038** 
  (0.003) (0.007) (0.010) (0.019) 
Total Days Deployed 0.000*** 0.000*** 0.000*** 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
          
Sample size 334,434 98,778 112,842 134,705 
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
The variables deployed only once, and deployed twice under OEF and OIF 
are statistically significant at the conventional level all four branches of service. The 
variable deployed three or more times under OEF/OIF is significant for the Army, Marine 
Corps and Navy. Deployed to Afghanistan or Iraq once is statistically significant for all 
branches except for the Navy. Deployed to Afghanistan or Iraq twice is statistically 
significant only for the Army and deployed to Afghanistan or Iraq three or more times is 
significant for the Army, Marine Corps and Navy. The reference group is comprised of 
those who were never deployed.  
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For the Army, the effect of those who were deployed only once for the 
average active duty enlisted person is a 16.9 percentage point change in the probability of 
being diagnosed with substance abuse. For those who were deployed once to Afghanistan 
or Iraq the results are even higher at an 18.1 percentage points change (adjusted 
percentage point difference is 16.9+1.2=18.1). Similar to the major depression findings 
for model 3, one deployment greatly increases the probability of substance abuse 
diagnosis for soldiers.  The effect of those soldiers who had two deployments under OEF 
and OIF is a 0.042 or 4.2 percentage points change in the probability of being diagnosed 
with substance abuse. The effect of three or more deployments is a an 8.0 percentage 
points change in the probability of diagnosis. The effect for soldiers on the probability of 
being diagnosed with substance abuse for those who had two deployments to Afghanistan 
or Iraq—a 15.4 percentage point change. Deployments of three or more under OEF and 
OIF is a 0.8 percentage points change and to Afghanistan or Iraq an added 2.4 percentage 
points change. This may indicate that due to past exposure to combat in Afghanistan or 
Iraq, Army personnel attempt to compensate with increased use of alcohol or other 
substances.  
The Marine Corps results indicate that those who were deployed only once 
for the average active duty enlisted Marine is a 0.102 or 10.2 percentage points change in 
the probability of being diagnosed with substance abuse. Deployed once to Afghanistan 
or Iraq further increases the probability of substance abuse by a 3.3 percentage points. 
The finding is consistent with the Army findings, that initial deployments pose the 
greatest risk of diagnosis with substance abuse. The effect of Marines who had two or 
more deployments under OEF and OIF has a 4.2 percentage points change in the 
probability of being diagnosed with substance abuse. Three or more deployments to any 
OEF or OIF location have a 4.2 percentage points effect on the probability of diagnosis. 
Among those who were deployed three or more times to Afghanistan or Iraq, the 
probability of diagnosis of substance abuse further increases by 1.4 percentage points or 
otherwise adjusted to 5.6 percentage points. This indicates that the initial deployment, 
similar to the Army, exhibits the greatest risk of diagnosis for substance abuse for 
Marines.   
 71
Looking at the Air Force analysis, one deployment to OEF and OIF shows 
the highest probability of diagnosis with a 4.1 percentage point change in the probability 
of being diagnosed with substance abuse. Initial deployments to Afghanistan or Iraq are 
even higher at a 5.8 percentage points change on the diagnosis of substance abuse. This 
shows that the largest risk for airmen is the initial deployment, specifically for those who 
were deployed to Afghanistan or Iraq. The final variable, two deployments under OEF 
and OIF shows the effect is a 2.0 percentage point change in the probability of being 
diagnosed with substance abuse, which is lower than the initial deployment probability.  
Results show that for the Navy the effect of the average sailor after their 
first deployment is a 0.072 or 7.2 percentage points increase in the probability of being 
diagnosed with substance abuse. Curiously, the effect of those who were deployed twice 
under OEF and OIF is only a 3.6 percentage points change. This indicates that similar to 
the other services, additional deployments decrease the risk of diagnosis with substance 
abuse. Sailors who deployed three or more times under OEF and OIF have only a 1.8 
percentage points change from the baseline (compared to those who never deployed)  in 
the probability of diagnosis with substance abuse, while those who were deployed strictly 
to Afghanistan or Iraq three or more times is negative (-3.8 percentage points, p<0.05). 
The result indicates that being deployed three or more times specifically to Afghanistan 
or Iraq for sailors has a -2.0 percentage points change, thus moderating the effect on 
being diagnosed with substance abuse.   
The findings support that the first deployment has the largest effect on 
substance abuse diagnosis in the Navy. While it would seem obvious that even more 
deployments (specifically to Afghanistan or Iraq) would increase the probability of 
diagnosis, this was shown to not be the case.    
d. Summary of Model 3 for Substance Abuse Across the Four 
Branches of Service 
Similar to the findings for major depression, these results demonstrate that 
multiple deployments increase the probability of being diagnosed with substance abuse 
for the average active duty enlisted person for the Army, Marine Corps, Air Force, and 
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Navy. The greatest probability of substance abuse issues occurs after the first 
deployment. There was actually a decrease in substance abuse problems with further 
deployments. For the Navy the negative coefficient, (-0.38), suggests there is no 
significant change in probability of being diagnosed with substance abuse for three or 
more deployments to Afghanistan or Iraq. Like the major depression findings, the results 
for substance abuse highlight the selection bias issue when using deployment history.  
Furthermore, deployment frequencies for all services indicate that personnel who 
deployed only once under OEF and OIF (regardless of location) have the highest 
probability of being diagnosed with substance abuse. This may be due to the same 
selection bias issue seen in the major depression model. Service members who were 
diagnosed with substance abuse after the first deployment were found unfit for future 
deployments. They were therefore, excluded from follow on deployment.  Model 3.a 
demonstrates that the results are similar whether total days deployed were included as the 
control variable. 
F. SUMMARY 
In this chapter, the descriptive statistics were presented and analyzed. The rate of 
diagnosis for major depression and substance abuse populations for deployment locations 
and durations (total days deployed) were analyzed and compared. Additionally key 
variables of the three multivariate probit models were presented and then analyzed.  
The descriptive statistics showed that the sample populations for major depression 
and substance abuse were similar in make-up and size. However, the overall rate of 
diagnosis for each sample was strikingly different. The rate of diagnosis for major 
depression tended to be a smaller percentage of the population, less than 3 percent 
whereas, substance abuse diagnosis was a much higher percentage, about 10 percent. The 
branch of service was also different for each diagnosis. The one exception, Marines, 
represent the lowest rate of diagnosis for major depression and substance abuse. The 
major depression overall rate was highest for the Air Force, but for substance abuse they 
had the second smallest overall rate of diagnosis. The Navy, on the other hand, 
represented the highest overall rate of diagnosis for substance abuse. Furthermore, 
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diagnosis by deployment characteristics showed that, for major depression and substance 
abuse, having ever deployed under any OEF and OIF location clearly increased the rate 
of diagnosis across the four branches of service.  
The multivariate analyses showed that for active duty military personnel who 
were ever deployed under OEF and OIF regardless of location, the probability was higher 
for being diagnosed with major depression or substance abuse compared to those who 
were never deployed. Those who were ever deployed to Afghanistan or Iraq had an even 
higher risk of being diagnosed with the two mental health conditions compared to those 
deployed to other known locations. Moreover, the analysis showed that deployments to a 
classified or unknown location and shore deployments for Navy, moderates the effect of 
being deployed under OEF and OIF.  
Multiple deployments for all branches of service increase the probability of being 
diagnosed with major depression or substance abuse. Deployment frequencies showed 
that active duty personnel who deployed only once under OEF and OIF had the highest 
probability of being diagnosed. This may again be a reflection of a selection bias. Those 
who were diagnosed after the first deployment were found unfit for future deployments, 
thus excluding them from subsequent deployment. The results for the Navy in particular 
showed the frequency of deployment to Afghanistan or Iraq of three or more times 
significantly decreased the probability of having a substance abuse diagnosis. When the 
total days of deployment were controlled for, the results were similar.  
The multivariate analyses also showed that the number of days deployed affects 
the rate of diagnosis for major depression and substance abuse. The magnitudes of the 
variables were highest for enlisted personnel who were deployed between 121 to 365 
days with two exceptions. Army and Marine enlisted showed the largest magnitude of 
substance abuse diagnosis for deployments for 1 to 120 days. 
Deployments increase the probability of being diagnosed with either of the mental 
health conditions compared to those who were never deployed, as was hypothesized. I 
also hypothesized that deployments to a classified or unknown location would increase 
the probability of being diagnosed with a mental health condition. However, the increases 
 74
were moderated. Enlisted personnel who were deployed to a classified or unknown 
location were still more likely to be diagnosed, but at a considerably smaller magnitude 
than deployments to other locations. 
The author hypothesized that the cumulative effect of deployments would 
increase the probability of diagnosis with substance abuse and major depression. The 
results showed that deployments do indeed raise the probability of diagnosis for either of 
the mental health issues, but the largest effect was for those who only had one 
deployment. The probability of diagnosis with substance abuse for the Army was when 
enlisted personnel who were deployed for 1 to 120 days, which may correspond to one 
deployment. Navy, Marines, and Air Force showed the largest magnitude for substance 
abuse diagnosis for deployments greater than 365 days, having the largest effect. The 
author speculates that onset of illness and time to diagnosis may be an unobservable 
factor for substance abuse.  The magnitude for major depression was slightly different 
revealing that deployments ranging from 121 to 180 days had a greater effect on the 
probability of diagnosis.  
In summary, the three multivariate analyses allowed the author to compare the 
effect of major depression and substance abuse across the four branches of service. Using 
multivariate analysis, it was possible to evaluate the effects of deployments by location 
and various lengths of deployment while holding other factors constant. The results 
supported what was hypothesized, but also provided valuable insights into the prevalence 
of major depression and substance abuse on the enlisted population who were deployed 




The results found in this study are consistent with existing literature that the 
prevalence of major depression and substance abuse adversely affects active duty military 
personnel despite the branch of service. Most existing literature focuses on Army and 
Marine Corps personnel and how these two mental health illnesses affect them. Similar to 
previous studies, the Army did indeed demonstrate a larger effect, placing them at the 
highest risk. This thesis expanded the analysis to include all four branches of service to 
analyze the prevalence of major depression and substance abuse to the total military. 
Evaluating deployment locations and durations of deployment during 2001 to 2006 
provides a broader understanding of how the two key mental health diagnoses affect the 
men and women who serve in the military.  
Chapter V presented the results of the multivariate analysis conducted for this 
thesis. Analysis showed that active duty enlisted personnel who were ever deployed 
under Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) between 
2001 and 2006 have a higher probability of being diagnosed with major depression or 
substance abuse than those who were never deployed. Those who were ever deployed to 
Iraq or Afghanistan have an even higher risk of being diagnosed with the two mental 
health conditions compared to deployment to other locations. On the other hand, 
deployment to a classified or unknown location appear to moderate the rate of major 
depression or substance abuse compared to deployment to other locations, although this 
group of enlisted still has a higher rate of the two mental health conditions compared to 
the non-deployed population.  
Deployments, clearly increase the risk of being diagnosed with major depression 
or substance abuse. The magnitude of risk varies depending on the number of days 
deployed per service and the diagnosis. For example, the probability of substance abuse 
diagnosis for the Army is greatest for deployments of 1 to 120 days whereas, the largest  
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risk of a major depression diagnosis is 121 to 180 days. The same trend is seen with the 
other branches of service. This appears to be a reflection of the different deployment 
tempos for each service.  
Multiple deployments increase the probability of being diagnosed with major 
depression and substance abuse. Moreover, deployment frequencies indicate that 
personnel who were deployed only once under OEF and OIF (regardless of location) 
have the highest probability of being diagnosed across all four branches of service. This 
may be a reflection of a selection bias: those who were diagnosed after the first 
deployment were found unfit for future deployments, thus excluding them from 
subsequent deployment. 
In general, the results support the finding that, across all four branches of service, 
deployments, especially to Iraq and Afghanistan, adversely affect the probability of 
active duty personnel being diagnosed with major depression or substance abuse.  
B. LIMITATIONS OF THE STUDY 
One limitation in this study was in the TRICARE and DMDC data. A significant 
number of missing EDIPNs and missing dates of birth existed within the TRICARE 
DEERS data from 2001 to 2006. The missing EDIPNs and dates of birth affect the size of 
the sample since they were omitted from the study. A more accurate analysis may have 
been possible with more observations. In addition to the missing dates of birth and 
EDIPNS, there were some observations with missing demographic information. 
However, they were not as significant. Given the large sample of major depression and 
substance abuse, it is unfortunate that a more in depth analysis is not possible because of 
the missing data.  
The reliance on clinical diagnosis information for major depression and substance 
abuse presents another limitation. While the clinical data from TRICARE is invaluable, it 
represents only active duty personnel who have sought or been referred to treatment. 




treatment are not represented in the data samples. Essentially, a selection bias may have 
occurred with individuals opting out of divulging the need for mental health evaluation 
and treatment.  
A limitation and area of improvement would be the omission of the officer 
population in this study. Inclusion of officer observations would provide a more 
comprehensive view of the effects of major depression and substance abuse rates on 
deployment characteristics.  
C. RECOMMENDATIONS 
This thesis has provided valuable information on the rate of two significant 
mental health illnesses for the Army, Marine Corps, Air Force, and Navy active duty 
enlisted personnel for the study period. The detailed information regarding the effects of 
major depression and substance abuse are of particular importance to the Air Force and 
Navy, since they are underrepresented in much of the literature. The evident increase in 
the probability of being diagnosed with major depression or substance abuse in the 
deployed population should encourage military planners to evaluate the number and 
lengths of deployment for each branch of service. Educational programs for service 
personnel provided pre- and post-deployment and centered on symptom identification, 
could help active duty personnel better understand and recognize when treatment might 
be needed. Given the significant probability of diagnosis with first deployments, 
aggressive educational preparation may be wise for these groups of individuals. An 
additional advantage of pre-educational programs may act as an “inoculation” for some 
service members against future development of major depression or substance abuse. 
Moreover, educational programs will aid in combating the negative perceptions 
surrounding mental health illness; thus, encouraging treatment at its earliest stage. 
Awareness is a powerful tool for combating and preventing diagnosis with major 
depression and substance abuse. Encouraging early treatment for major depression or 
substance abuse ensures readiness is not adversely impacted. Major depression and 
substance abuse are treatable! 
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APPENDIX A. EFFECT OF DEPLOYMENT ON RATE OF MAJOR 
DEPRESSION DIAGNOSED 
Table 21.   Model 1: Major Depression 
 Model 1–Major Depression 
 Army Marines Air Force Navy 
Location of Deployment (reference group is not 
deployed under OEF/OIF) 
        
Ever Deployed 0.037*** 0.018*** 0.014*** 0.023*** 
  (0.001) (0.001) (0.001) (0.002) 
Ever Deployed to Afghanistan or Iraq 0.002** 0.006*** 0.001 0.011*** 
  (0.001) (0.001) (0.002) (0.004) 
Ever Deployed to Classified Location -0.011*** -0.004*** -0.007*** -0.005*** 
  (0.001) (0.001) (0.001) (0.001) 
Ever Deployed to Shore       -0.013*** 
        (0.001) 
Military Occupational Specialty (reference group is 
Combat Arms)         
Combat Support 0.000 -0.000   0.002 
  (0.001) (0.001)   (0.002) 
Combat Service Support 0.001* 0.002** 0.008*** -0.001 
  (0.001) (0.001) (0.001) (0.002) 
Aviation   0.005***   -0.001 
    (0.001)   (0.003) 
Medical -0.002***   -0.021*** 0.013*** 
  (0.001)   (0.001) (0.003) 
Other MOS 0.009*** 0.043*** 0.058*** 0.007*** 
  (0.001) (0.003) (0.004) (0.002) 
Rank (reference group is E7–E9)         
E1_E3 0.011*** 0.018*** 0.021*** 0.002 
  (0.001) (0.002) (0.004) (0.002) 
E4 0.011*** 0.023*** 0.029*** 0.009*** 
  (0.001) (0.005) (0.004) (0.002) 
E5 0.005*** 0.035*** 0.023*** 0.008*** 
  (0.001) (0.006) (0.003) (0.002) 
E6 0.003*** 0.027*** 0.012*** 0.004** 
  (0.001) (0.005) (0.003) (0.002) 
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 Model 1–Major Depression 
 Army Marines Air Force Navy 
Demographics         
race (reference group is White)         
African-American -0.006*** -0.004*** -0.008*** -0.010*** 
  (0.000) (0.001) (0.001) (0.001) 
Hispanic -0.004*** -0.003*** -0.007*** -0.004*** 
  (0.001) (0.001) (0.002) (0.001) 
Asian -0.006*** -0.004*** -0.012*** -0.010*** 
  (0.001) (0.001) (0.002) (0.001) 
Other races -0.000 -0.004*** -0.004** -0.002* 
  (0.001) (0.001) (0.002) (0.001) 
Gender (reference group is male)         
Female 0.037*** 0.045*** 0.053*** 0.054*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.009*** -0.008*** -0.008*** -0.008*** 
  (0.001) (0.001) (0.001) (0.001) 
Age         
Age at MD diagnosis date 0.001*** 0.001*** 0.000** 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
Age at MD diagnosis or DEERS extraction date is 
missing 0.145*** 0.028*** 0.136*** 0.116*** 
  (0.012) (0.008) (0.018) (0.012) 
FYI (reference group is 2001)         
FY02 -0.003*** -0.002 -0.008*** -0.006*** 
  (0.001) (0.001) (0.001) (0.001) 
FY03 -0.008*** -0.005*** -0.007*** -0.004*** 
  (0.001) (0.001) (0.001) (0.001) 
FY04 -0.010*** -0.001 -0.007*** -0.002 
  (0.001) (0.001) (0.001) (0.001) 
FY05 -0.008*** -0.001 -0.011*** -0.000 
  (0.001) (0.001) (0.001) (0.001) 
FY06 -0.012*** -0.007*** -0.015*** -0.008*** 
  (0.001) (0.001) (0.001) (0.001) 
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 Model 1–Major Depression 
 Army Marines Air Force Navy 
Sample size 334,871 98,808 112,956 134,734 
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
Table 22.   Model 2: Major Depression 
 Model 2–Major Depression 
Effect of Total Days Deployed on Rate of Major 
Depression 
Army Marines Air Force Navy 
Deployment Days (reference group 0 days 
deployed) 
        
Days Deployed 1 to 120 0.040*** 0.018*** 0.016*** 0.013*** 
  (0.001) (0.001) (0.001) (0.002) 
Days Deployed 121 to 180 0.079*** 0.013* 0.103*** 0.077*** 
  (0.011) (0.007) (0.017) (0.016) 
Days Deployed 181 to 365 0.053*** 0.006* 0.034*** 0.077*** 
  (0.004) (0.003) (0.011) (0.011) 
Days Deployed 365 plus 0.048*** 0.017*** 0.077*** 0.074*** 
  (0.004) (0.006) (0.025) (0.021) 
Ever Deployed to Afghanistan or Iraq 0.001* 0.006*** 0.001 0.011*** 
  (0.001) (0.001) (0.002) (0.004) 
Ever Deployed to Classified Location -0.011*** -0.004*** -0.007*** -0.007*** 
  (0.001) (0.001) (0.001) (0.001) 
Military Occupational Specialty (reference 
group is Combat Arms)         
Combat Support 0.000 -0.000   0.002 
  (0.001) (0.001)   (0.002) 
Combat Service Support 0.001* 0.002** 0.008*** -0.001 
  (0.001) (0.001) (0.001) (0.002) 
Aviation   0.004***   -0.001 
    (0.001)   (0.003) 
Medical -0.002***   -0.020*** 0.013*** 
  (0.001)   (0.002) (0.003) 
Other MOS 0.006*** 0.036*** 0.054*** 0.007*** 
  (0.001) (0.003) (0.004) (0.002) 
Rank (reference group is E7–E9)         
E1_E3 0.010*** 0.017*** 0.021*** 0.003 
  (0.001) (0.002) (0.004) (0.002) 
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 Model 2–Major Depression 
Effect of Total Days Deployed on Rate of Major 
Depression 
Army Marines Air Force Navy 
E4 0.010*** 0.023*** 0.028*** 0.009*** 
  (0.001) (0.005) (0.004) (0.002) 
E5 0.005*** 0.034*** 0.023*** 0.008*** 
  (0.001) (0.006) (0.003) (0.002) 
E6 0.003*** 0.025*** 0.012*** 0.004** 
  (0.001) (0.005) (0.003) (0.002) 
Demographics         
race (reference group is White)         
African-American -0.006*** -0.004*** -0.008*** -0.009*** 
  (0.000) (0.001) (0.001) (0.001) 
Hispanic -0.003*** -0.003*** -0.008*** -0.005*** 
  (0.001) (0.001) (0.002) (0.001) 
Asian -0.006*** -0.004*** -0.011*** -0.010*** 
  (0.001) (0.001) (0.002) (0.001) 
Other races -0.000 -0.004*** -0.004** -0.002* 
  (0.001) (0.001) (0.002) (0.001) 
Gender (reference group is male)         
Female 0.037*** 0.045*** 0.051*** 0.052*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.008*** -0.008*** -0.008*** -0.008*** 
  (0.001) (0.001) (0.001) (0.001) 
Age         
Age at MD diagnosis date 0.001*** 0.001*** 0.000** 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
Age at MD diagnosis or DEERS extraction date is 
missing 0.152*** 0.033*** 0.135*** 0.113*** 
  (0.012) (0.009) (0.018) (0.012) 
FYI (reference group is 2001)         
FY02 -0.003*** -0.002 -0.008*** -0.007*** 
  (0.001) (0.001) (0.001) (0.001) 
FY03 -0.007*** -0.005*** -0.007*** -0.005*** 
  (0.001) (0.001) (0.001) (0.001) 
FY04 -0.010*** -0.000 -0.007*** -0.003** 
  (0.001) (0.001) (0.001) (0.001) 
FY05 -0.008*** -0.001 -0.011*** 0.000 
  (0.001) (0.001) (0.001) (0.001) 
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 Model 2–Major Depression 
Effect of Total Days Deployed on Rate of Major 
Depression 
Army Marines Air Force Navy 
FY06 -0.010*** -0.007*** -0.015*** -0.006*** 
  (0.001) (0.001) (0.001) (0.001) 
          
Sample size 334,871 98,808 112,956 134,734 
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
Table 23.   Model 3: Major Depression 
 Model 3–Major Depression 
  Army Marines Air Force Navy 
Duration of Deployment (reference group is not 
deployed)         
Deployed only once 0.064*** 0.034*** 0.026*** 0.010*** 
  (0.002) (0.003) (0.002) (0.001) 
Deployed twice 0.019*** 0.003 0.001 -0.004*** 
  (0.003) (0.002) (0.002) (0.001) 
Deployed three or more times 0.014*** 0.003 -0.006*** -0.008*** 
  (0.002) (0.002) (0.002) (0.002) 
Deployed to Afghanistan or Iraq at only once 0.001 0.006*** 0.004 0.028*** 
  (0.001) (0.002) (0.003) (0.006) 
Deployed to Afghanistan or Iraq twice 0.025*** 0.004 -0.002 0.014 
  (0.003) (0.003) (0.004) (0.009) 
Deployed to Afghanistan or Iraq three or  more 
times 0.001 0.012*** -0.002 -0.010 
  (0.001) (0.004) (0.006) (0.008) 
Military Occupational Specialty (reference 
group is Combat Arms)         
Combat Support 0.000 -0.000   0.001 
  (0.001) (0.001)   (0.002) 
Combat Service Support 0.001 0.002* 0.007*** -0.001 
  (0.001) (0.001) (0.001) (0.002) 
Aviation   0.004***   -0.001 
    (0.001)   (0.003) 
Medical -0.002***   -0.020*** 0.014*** 
  (0.001)   (0.001) (0.003) 
Other MOS 0.008*** 0.042*** 0.055*** 0.007*** 
  (0.001) (0.003) (0.004) (0.001) 
Rank (reference group is E7–E9)         
E1_E3 0.010*** 0.017*** 0.021*** 0.003 
  (0.001) (0.002) (0.004) (0.002) 
E4 0.010*** 0.021*** 0.028*** 0.010*** 
  (0.001) (0.005) (0.004) (0.002) 
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 Model 3–Major Depression 
  Army Marines Air Force Navy 
E5 0.006*** 0.032*** 0.024*** 0.008*** 
  (0.001) (0.006) (0.003) (0.002) 
E6 0.004*** 0.026*** 0.013*** 0.004** 
  (0.001) (0.005) (0.003) (0.002) 
Demographics         
race (reference group is White)         
African-American -0.006*** -0.004*** -0.008*** -0.010*** 
  (0.000) (0.001) (0.001) (0.001) 
Hispanic -0.004*** -0.003*** -0.007*** -0.005*** 
  (0.001) (0.001) (0.002) (0.001) 
Asian -0.006*** -0.004*** -0.011*** -0.010*** 
  (0.001) (0.001) (0.002) (0.001) 
Other races 0.000 -0.004*** -0.004** -0.002* 
  (0.001) (0.001) (0.002) (0.001) 
Gender (reference group is male)         
Female 0.036*** 0.044*** 0.051*** 0.053*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.009*** -0.008*** -0.008*** -0.008*** 
  (0.001) (0.001) (0.001) (0.001) 
Age         
Age at MD diagnosis date 0.000*** 0.001*** 0.000 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
Age at MD diagnosis or DEERS extraction date is 
missing 0.147*** 0.026*** 0.135*** 0.115*** 
  (0.012) (0.008) (0.018) (0.012) 
FYI (reference group is 2001)         
FY02 -0.003*** -0.002 -0.007*** -0.007*** 
  (0.001) (0.001) (0.001) (0.001) 
FY03 -0.007*** -0.005*** -0.006*** -0.005*** 
  (0.001) (0.001) (0.001) (0.001) 
FY04 -0.010*** -0.001 -0.007*** -0.003** 
  (0.001) (0.001) (0.001) (0.001) 
FY05 -0.008*** -0.002 -0.011*** -0.000 
  (0.001) (0.001) (0.001) (0.001) 
FY06 -0.011*** -0.007*** -0.016*** -0.007*** 
  (0.001) (0.001) (0.001) (0.001) 
          
Sample size 334,871 98,808 112,956  134,734  
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
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Table 24.   Model 3.a: Major Depression 
 Model 3.a 
 Army Marines Air Force Navy 
Duration of Deployment (reference group is not 
deployed)         
Deployed only once 0.067*** 0.035*** 0.026*** 0.011*** 
  (0.002) (0.003) (0.002) (0.001) 
Deployed twice 0.021*** 0.003* 0.002 -0.004*** 
  (0.003) (0.002) (0.002) (0.001) 
Deployed three or more times 0.015*** 0.003 -0.005*** -0.008*** 
  (0.002) (0.002) (0.002) (0.002) 
Deployed to Afghanistan or Iraq at only once 0.001 0.006*** 0.003 0.027*** 
  (0.001) (0.002) (0.003) (0.006) 
Deployed to Afghanistan or Iraq twice 0.024*** 0.004 -0.002 0.014 
  (0.003) (0.003) (0.004) (0.009) 
Deployed to Afghanistan or Iraq three or more 
times 0.000 0.012*** -0.002 -0.010 
  (0.001) (0.004) (0.006) (0.008) 
Total Days Deployed 0.000*** 0.000*** 0.000*** 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
Military Occupational Specialty (reference 
group is Combat Arms)         
Combat Support 0.000 -0.000   0.001 
  (0.001) (0.001)   (0.002) 
Combat Service Support 0.001 0.002* 0.007*** -0.001 
  (0.001) (0.001) (0.001) (0.002) 
Aviation   0.004***   -0.001 
    (0.001)   (0.003) 
Medical -0.002***   -0.020*** 0.014*** 
  (0.001)   (0.001) (0.003) 
Other MOS 0.006*** 0.037*** 0.052*** 0.006*** 
  (0.001) (0.003) (0.004) (0.001) 
Rank (reference group is E7–E9)         
E1_E3 0.009*** 0.017*** 0.020*** 0.002 
  (0.001) (0.002) (0.004) (0.002) 
E4 0.010*** 0.020*** 0.028*** 0.009*** 
  (0.001) (0.005) (0.004) (0.002) 
E5 0.005*** 0.031*** 0.023*** 0.008*** 
  (0.001) (0.006) (0.003) (0.002) 
E6 0.003*** 0.025*** 0.012*** 0.004** 
  (0.001) (0.005) (0.003) (0.002) 
Demographics         
race (reference group is White)         
African-American -0.006*** -0.004*** -0.008*** -0.010*** 
  (0.000) (0.001) (0.001) (0.001) 
Hispanic -0.003*** -0.003*** -0.007*** -0.004*** 
  (0.001) (0.001) (0.002) (0.001) 
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 Model 3.a 
 Army Marines Air Force Navy 
Asian -0.006*** -0.004*** -0.011*** -0.010*** 
  (0.001) (0.001) (0.002) (0.001) 
Other races 0.000 -0.004*** -0.003** -0.002** 
  (0.001) (0.001) (0.002) (0.001) 
Gender (reference group is male)         
Female 0.036*** 0.044*** 0.050*** 0.052*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.009*** -0.008*** -0.008*** -0.008*** 
  (0.001) (0.001) (0.001) (0.001) 
Age         
Age at MD diagnosis date 0.000*** 0.001*** 0.000 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
Age at MD diagnosis or DEERS extraction date is 
missing 0.153*** 0.028*** 0.133*** 0.112*** 
  (0.012) (0.008) (0.018) (0.012) 
FYI (reference group is 2001)         
FY02 -0.003*** -0.002 -0.008*** -0.006*** 
  (0.001) (0.001) (0.001) (0.001) 
FY03 -0.007*** -0.005*** -0.006*** -0.005*** 
  (0.001) (0.001) (0.001) (0.001) 
FY04 -0.010*** -0.001 -0.007*** -0.002* 
  (0.001) (0.001) (0.001) (0.001) 
FY05 -0.007*** -0.002 -0.011*** 0.000 
  (0.001) (0.001) (0.001) (0.001) 
FY06 -0.010*** -0.007*** -0.015*** -0.006*** 
  (0.001) (0.001) (0.001) (0.001) 
          
Sample size 334,871 98,808 112,954 134,724 
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
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APPENDIX B. EFFECT OF DEPLOYMENT ON RATE OF 
SUBSTANCE ABUSE DIAGNOSED 
Table 25.   Model 1: Substance Abuse 
 Model 1–Substance Abuse 
 Army Marines Air Force Navy 
Location of Deployment (reference group is 
not deployed under OEF/OIF) 
    -    
Ever Deployed 0.116*** 0.061*** 0.030*** 0.074*** 
  (0.002) (0.003) (0.002) (0.005) 
Ever Deployed to Afghanistan or Iraq 0.016*** 0.023*** 0.008** -0.008 
  (0.002) (0.004) (0.003) (0.007) 
Ever Deployed to Classified Location -0.043*** 0.004 -0.017*** -0.002 
  (0.001) (0.003) (0.002) (0.003) 
Ever Deployed to Shore       -0.021*** 
        (0.003) 
Military Occupational Specialty (reference 
group is Combat Arms)         
Combat Support -0.000 0.007***   -0.012*** 
  (0.002) (0.002)   (0.004) 
Combat Service Support -0.003** 0.009*** 0.014*** -0.010** 
  (0.001) (0.002) (0.002) (0.004) 
Aviation   0.011***   0.010* 
    (0.002)   (0.006) 
Medical -0.007***   -0.018** 0.002 
  (0.001)   (0.009) (0.005) 
Other MOS -0.011*** 0.031*** 0.033*** -0.002 
  (0.001) (0.004) (0.004) (0.004) 
Rank (reference group is E7–E9)         
E1_E3 0.064*** 0.082*** 0.039*** 0.052*** 
  (0.003) (0.005) (0.006) (0.005) 
E4 0.052*** 0.100*** 0.045*** 0.055*** 
  (0.003) (0.011) (0.006) (0.006) 
E5 0.027*** 0.090*** 0.037*** 0.040*** 
  (0.003) (0.010) (0.005) (0.005) 
E6 0.016*** 0.052*** 0.013*** 0.011*** 
  (0.003) (0.009) (0.004) (0.004) 
Demographics         
race (reference group is White)         
African-American -0.012*** -0.019*** -0.023*** -0.038*** 
  (0.001) (0.002) (0.002) (0.002) 
Hispanic -0.019*** -0.012*** -0.012*** -0.014*** 
  (0.001) (0.002) (0.003) (0.003) 
Asian -0.023*** -0.025*** -0.030*** -0.050*** 
  (0.002) (0.003) (0.003) (0.002) 
Other races -0.005*** -0.008*** -0.016*** -0.013*** 
  (0.002) (0.002) (0.003) (0.002) 
Gender (reference group is male)         
Female -0.017*** 0.007** 0.002 -0.019*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.007*** 0.000 0.001 0.003 
  (0.001) (0.002) (0.002) (0.002) 
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 Model 1–Substance Abuse 
 Army Marines Air Force Navy 
Age         
Age at SA diagnosis date -0.000*** 0.003*** -0.001*** 0.000** 
  (0.000) (0.000) (0.000) (0.000) 
Age at SA diagnosis or DEERS extraction date is 
missing 0.045*** 0.098*** 0.022* 0.043*** 
  (0.010) (0.020) (0.013) (0.012) 
FYI (reference group is 2001)         
FY02 -0.018*** -0.003 -0.020*** -0.012*** 
  (0.001) (0.003) (0.002) (0.002) 
FY03 -0.046*** -0.030*** -0.029*** -0.038*** 
  (0.001) (0.002) (0.002) (0.002) 
FY04 -0.059*** -0.037*** -0.034*** -0.042*** 
  (0.001) (0.002) (0.002) (0.002) 
FY05 -0.065*** -0.046*** -0.038*** -0.052*** 
  (0.001) (0.002) (0.002) (0.002) 
FY06 -0.078*** -0.059*** -0.044*** -0.069*** 
  (0.001) (0.002) (0.002) (0.002) 
          
Sample size 334,434 98,778 112,846 134,711 
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
Table 26.   Model 2: Substance Abuse 
Effect of Total Days Deployed on Rate of 
Substance Abuse Model 2–Substance Abuse 
 Army Marines Air Force Navy 
Deployment Days (reference group 0 days 
deployed) 
        
Days Deployed 1 to 120 0.119*** 0.064*** 0.031*** 0.058*** 
  (0.002) (0.003) (0.002) (0.004) 
Days Deployed 121 to 180 0.070*** 0.080*** 0.050*** 0.077*** 
  (0.013) (0.022) (0.018) (0.023) 
Days Deployed 181 to 365 0.094*** 0.074*** 0.039** 0.093*** 
  (0.006) (0.012) (0.017) (0.015) 
Days Deployed 365 plus 0.100*** 0.080*** 0.053** 0.116*** 
  (0.007) (0.016) (0.027) (0.029) 
Ever Deployed to Afghanistan or Iraq 0.016*** 0.022*** 0.008** -0.007 
  (0.002) (0.003) (0.003) (0.007) 
Ever Deployed to Classified Location -0.042*** 0.003 -0.017*** -0.004 
  (0.001) (0.003) (0.002) (0.003) 
Military Occupational Specialty (reference 
group is Combat Arms)         
Combat Support -0.000 0.007***   -0.012*** 
  (0.002) (0.002)   (0.004) 
Combat Service Support -0.003** 0.009*** 0.013*** -0.010** 
  (0.001) (0.002) (0.002) (0.004) 
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Effect of Total Days Deployed on Rate of 
Substance Abuse Model 2–Substance Abuse 
 Army Marines Air Force Navy 
Aviation   0.011***   0.011* 
    (0.002)   (0.006) 
Medical -0.007***   -0.016* 0.002 
  (0.001)   (0.009) (0.005) 
Other MOS -0.016*** 0.013*** 0.031*** -0.003 
  (0.001) (0.004) (0.004) (0.004) 
Rank (reference group is E7–E9)         
E1_E3 0.061*** 0.081*** 0.039*** 0.053*** 
  (0.003) (0.005) (0.006) (0.005) 
E4 0.049*** 0.097*** 0.045*** 0.056*** 
  (0.003) (0.011) (0.006) (0.006) 
E5 0.026*** 0.087*** 0.037*** 0.040*** 
  (0.003) (0.010) (0.005) (0.005) 
E6 0.015*** 0.050*** 0.013*** 0.011*** 
  (0.002) (0.008) (0.004) (0.004) 
Demographics         
race (reference group is White)         
African-American -0.011*** -0.019*** -0.023*** -0.038*** 
  (0.001) (0.002) (0.002) (0.002) 
Hispanic -0.018*** -0.012*** -0.012*** -0.015*** 
  (0.001) (0.002) (0.003) (0.003) 
Asian -0.022*** -0.025*** -0.030*** -0.050*** 
  (0.002) (0.003) (0.003) (0.002) 
Other races -0.005*** -0.008*** -0.016*** -0.014*** 
  (0.002) (0.002) (0.003) (0.002) 
Gender (reference group is male)         
Female -0.017*** 0.007** 0.001 -0.020*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.006*** 0.000 0.001 0.002 
  (0.001) (0.002) (0.002) (0.002) 
Age         
Age at SA diagnosis date -0.000*** 0.003*** -0.001*** 0.000** 
  (0.000) (0.000) (0.000) (0.000) 
Age at SA diagnosis or DEERS extraction date is 
missing 0.051*** 0.130*** 0.022* 0.039*** 
  (0.010) (0.023) (0.013) (0.012) 
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Effect of Total Days Deployed on Rate of 
Substance Abuse Model 2–Substance Abuse 
 Army Marines Air Force Navy 
FYI (reference group is 2001)         
FY02 -0.018*** -0.004 -0.020*** -0.013*** 
  (0.001) (0.003) (0.002) (0.002) 
FY03 -0.045*** -0.030*** -0.029*** -0.040*** 
  (0.001) (0.002) (0.002) (0.002) 
FY04 -0.058*** -0.037*** -0.034*** -0.043*** 
  (0.001) (0.002) (0.002) (0.002) 
FY05 -0.063*** -0.046*** -0.038*** -0.051*** 
  (0.001) (0.002) (0.002) (0.002) 
FY06 -0.076*** -0.058*** -0.044*** -0.067*** 
  (0.001) (0.002) (0.002) (0.002) 
          
Sample size 334,434 98,778 112,846 134,711 
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
Table 27.   Model 3: Substance Abuse 
 Model 3–Substance Abuse 
  Army Marines Air Force Navy 
Duration of Deployment (reference group is 
not deployed)         
Deployed only once 0.169*** 0.102*** 0.041*** 0.072*** 
  (0.004) (0.005) (0.003) (0.003) 
Deployed twice 0.042*** 0.042*** 0.020*** 0.036*** 
  (0.005) (0.005) (0.003) (0.003) 
Deployed three or more times 0.080*** 0.042*** 0.001 0.018*** 
  (0.003) (0.006) (0.003) (0.005) 
Deployed to Afghanistan or Iraq at only once 0.012*** 0.033*** 0.017*** 0.001 
  (0.003) (0.005) (0.005) (0.010) 
Deployed to Afghanistan or Iraq twice 0.112*** 0.005 0.004 -0.001 
  (0.008) (0.006) (0.006) (0.013) 
Deployed to Afghanistan or Iraq three or more 
times 0.024*** 0.014** 0.008 -0.038** 
  (0.003) (0.007) (0.010) (0.019) 
Military Occupational Specialty (reference 
group is Combat Arms)         
Combat Support -0.000 0.006**   -0.013*** 
  (0.002) (0.002)   (0.004) 
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 Model 3–Substance Abuse 
  Army Marines Air Force Navy 
Combat Service Support -0.003*** 0.007*** 0.013*** -0.010** 
  (0.001) (0.002) (0.002) (0.004) 
Aviation   0.010***   0.010* 
    (0.002)   (0.006) 
Medical -0.007***   -0.018** 0.003 
  (0.001)   (0.009) (0.005) 
Other MOS -0.012*** 0.029*** 0.032*** -0.002 
  (0.001) (0.004) (0.004) (0.004) 
Rank (reference group is E7–E9)         
E1_E3 0.061*** 0.082*** 0.040*** 0.054*** 
  (0.003) (0.005) (0.006) (0.005) 
E4 0.051*** 0.096*** 0.046*** 0.056*** 
  (0.003) (0.011) (0.006) (0.006) 
E5 0.027*** 0.086*** 0.038*** 0.040*** 
  (0.003) (0.010) (0.005) (0.005) 
E6 0.016*** 0.053*** 0.014*** 0.011*** 
  (0.003) (0.009) (0.004) (0.004) 
Demographics         
race (reference group is White)         
African-American -0.011*** -0.019*** -0.023*** -0.038*** 
  (0.001) (0.002) (0.002) (0.002) 
Hispanic -0.018*** -0.012*** -0.012*** -0.014*** 
  (0.001) (0.002) (0.003) (0.003) 
Asian -0.023*** -0.025*** -0.029*** -0.050*** 
  (0.002) (0.003) (0.003) (0.002) 
Other races -0.004** -0.009*** -0.016*** -0.014*** 
  (0.002) (0.002) (0.003) (0.002) 
Gender (reference group is male)         
Female -0.018*** 0.007* 0.002 -0.019*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.007*** 0.001 0.000 0.002 
  (0.001) (0.002) (0.002) (0.002) 
Age         
Age at SA diagnosis date -0.001*** 0.003*** -0.001*** 0.000* 
  (0.000) (0.000) (0.000) (0.000) 
Age at SA diagnosis or DEERS extraction date is 
missing 0.048*** 0.098*** 0.023* 0.043*** 
  (0.010) (0.020) (0.013) (0.012) 
FYI (reference group is 2001)         
FY02 -0.018*** -0.003 -0.019*** -0.012*** 
  (0.001) (0.003) (0.002) (0.002) 
FY03 -0.045*** -0.030*** -0.028*** -0.039*** 
  (0.001) (0.002) (0.002) (0.002) 
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 Model 3–Substance Abuse 
  Army Marines Air Force Navy 
FY04 -0.059*** -0.037*** -0.034*** -0.043*** 
  (0.001) (0.002) (0.002) (0.002) 
FY05 -0.064*** -0.046*** -0.038*** -0.052*** 
  (0.001) (0.002) (0.002) (0.002) 
FY06 -0.077*** -0.059*** -0.045*** -0.068*** 
  (0.001) (0.002) (0.002) (0.002) 
          
Sample size 334,434 98,778 112,846 134,711 
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
 
Table 28.   Model 3.a: Substance Abuse 
 Model 3.a 
  Army Marines Air Force Navy 
Duration of Deployment (reference group is 
not deployed)         
Deployed only once 0.173*** 0.103*** 0.041*** 0.073*** 
  (0.004) (0.005) (0.003) (0.003) 
Deployed twice 0.045*** 0.043*** 0.020*** 0.036*** 
  (0.005) (0.005) (0.003) (0.003) 
Deployed three or more times 0.082*** 0.043*** 0.001 0.019*** 
  (0.003) (0.006) (0.003) (0.005) 
Deployed to Afghanistan or Iraq at only once 0.011*** 0.033*** 0.017*** 0.001 
  (0.003) (0.005) (0.005) (0.010) 
Deployed to Afghanistan or Iraq twice 0.110*** 0.005 0.004 -0.001 
  (0.008) (0.006) (0.006) (0.013) 
Deployed to Afghanistan or Iraq three or more 
times 0.023*** 0.013** 0.008 -0.038** 
  (0.003) (0.007) (0.010) (0.019) 
Total Days Deployed 0.000*** 0.000*** 0.000*** 0.000*** 
  (0.000) (0.000) (0.000) (0.000) 
Military Occupational Specialty (reference 
group is Combat Arms)         
Combat Support 0.000 0.006**   -0.013*** 
  (0.002) (0.002)   (0.004) 
Combat Service Support -0.003*** 0.007*** 0.013*** -0.010** 
  (0.001) (0.002) (0.002) (0.004) 
Aviation   0.010***   0.010* 
    (0.002)   (0.006) 
Medical -0.007***   -0.017** 0.003 
  (0.001)   (0.009) (0.005) 
Other MOS -0.015*** 0.017*** 0.031*** -0.003 
  (0.001) (0.004) (0.004) (0.004) 
Rank (reference group is E7–E9)         
 E1_E3 0.059*** 0.080*** 0.039*** 0.053*** 
  (0.003) (0.005) (0.006) (0.005) 
E4 0.049*** 0.093*** 0.045*** 0.056*** 
  (0.003) (0.011) (0.006) (0.006) 
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  Army Marines Air Force Navy 
E5 0.026*** 0.083*** 0.038*** 0.040*** 
  (0.003) (0.010) (0.005) (0.005) 
E6 0.015*** 0.050*** 0.013*** 0.011*** 
  (0.002) (0.008) (0.004) (0.004) 
Demographics         
race (reference group is White)         
African-American -0.011*** -0.019*** -0.023*** -0.038*** 
  (0.001) (0.002) (0.002) (0.002) 
Hispanic -0.018*** -0.012*** -0.012*** -0.014*** 
  (0.001) (0.002) (0.003) (0.003) 
Asian -0.022*** -0.025*** -0.029*** -0.049*** 
  (0.002) (0.003) (0.003) (0.002) 
Other races -0.004** -0.009*** -0.016*** -0.014*** 
  (0.002) (0.002) (0.003) (0.002) 
Gender (reference group is male)         
Female -0.018*** 0.007* 0.001 -0.020*** 
  (0.001) (0.004) (0.002) (0.002) 
Marital status (reference group is married)         
Single -0.007*** 0.000 0.001 0.003 
  (0.001) (0.002) (0.002) (0.002) 
Age         
Age at SA diagnosis date -0.001*** 0.003*** -0.001*** 0.000* 
  (0.000) (0.000) (0.000) (0.000) 
Age at SA diagnosis or DEERS extraction date is 
missing 0.051*** 0.117*** 0.022* 0.040*** 
  (0.010) (0.022) (0.013) (0.012) 
FYI (reference group is 2001)         
FY02 -0.018*** -0.004 -0.019*** -0.012*** 
  (0.001) (0.003) (0.002) (0.002) 
FY03 -0.045*** -0.030*** -0.028*** -0.039*** 
  (0.001) (0.002) (0.002) (0.002) 
FY04 -0.058*** -0.037*** -0.034*** -0.042*** 
  (0.001) (0.002) (0.002) (0.002) 
FY05 -0.063*** -0.046*** -0.038*** -0.051*** 
  (0.001) (0.002) (0.002) (0.002) 
FY06 -0.075*** -0.058*** -0.044*** -0.068*** 
  (0.001) (0.002) (0.002) (0.002) 
          
Sample size 334,434 98,778 112,842 134,705 
Note: Year dummies are included.      
Standard errors in parentheses     
*** p<0.01, ** p<0.05, * p<0.1     
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